Header Logo

SURENA MATIN

TitleProfessor
InstitutionMD Anderson
DepartmentUrology
Address1155 Pressler St
Houston TX 77030-3721
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Zhao J, Shen Y, Guo M, Matin SF, Hansel DE, Guo CC. Diagnostic accuracy of upper tract urothelial carcinoma using biopsy, urinary cytology, and nephroureterectomy specimens: A tertiary cancer center experience. Am J Clin Pathol. 2024 Nov 04; 162(5):492-499. PMID: 38860463.
      Citations:    Fields:    
    2. Shanker MD, Yu ZH, Yang J, Matin S, Campbell MT, Msaouel P, Tannir N, Prajapati S, Ding Y, Lee B, Sobremonte A, Tang C. MR-Linac-guided stereotactic radiotherapy for CT-indiscernible intravascular renal cell carcinoma tumours. BJUI Compass. 2024 Oct; 5(10):913-915. PMID: 39416759; PMCID: PMC11479802.
      Citations:    
    3. Abdelsalam ME, Mecci N, Awad A, Bassett RL, Odisio BC, Habibollahi P, Lu T, Irwin D, Karam JA, Matin SF, Ahrar K. Magnetic-Resonance-Imaging-Guided Cryoablation for Solitary-Biopsy-Proven Renal Cell Carcinoma: A Tertiary Cancer Center Experience. Cancers (Basel). 2024 May 10; 16(10). PMID: 38791894; PMCID: PMC11119189.
      Citations:    
    4. Tang C, Hara K, Sherry AD, Serrano AG, Kostousov LV, Hernandez SD, Lu W, Shen L, Shah AY, Jonasch E, Karam JA, Matin SF, Tannir N, Wang J, Msaouel P, Sircar K, Solis L. YIA24-001: Spatial Evolution of Immune Cell Dysfunction During Development of Oligometastatic Renal Cell Carcinoma: Secondary Analysis of a Prospective Trial. J Natl Compr Canc Netw. 2024 Apr 05; 22(2.5). PMID: 38579843.
      Citations:    Fields:    Translation:Humans
    5. Pal SK, Grivas P, Gupta S, Dizman N, Zengin Z, Valderrama BP, Rodriguez-Vida A, Roghmann F, Sevillano Fernandez E, Matin SF, Loriot Y, Sridhar SS, Sonpavde G, Fleming MT, Lerner SP, Bellmunt J, Master V, Tripathi A, Davis K, van Veenhuyzen D, Weng R, Daneshmand S. Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial. Eur Urol. 2024 Apr 04. PMID: 38580518.
      Citations:    Fields:    
    6. Matin SF, Adibi M, Shah AY, Alhalabi O, Corn P, Guo C, Amirtharaj R, Xiao L, Lange S, Duose DY, Wang S, Pal S, Campbell MT. Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma. J Urol. 2024 Jun; 211(6):784-793. PMID: 38573872; PMCID: PMC11251863.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    7. Abdelsalam ME, Lu T, Baiomy A, Awad A, Odisio BC, Habibollahi P, Irwin D, Karam JA, Matin SF, Stafford J, Ahrar K. Magnetic resonance imaging-guided renal biopsy shows high safety and diagnostic yield: a tertiary cancer center experience. Eur Radiol. 2024 Sep; 34(9):5551-5560. PMID: 38400904.
      Citations:    Fields:    Translation:Humans
    8. Ozambela M, McCormick BZ, Rudzinski JK, Pieretti AC, Gonz?lez GMN, Meissner MA, Papadopoulos JN, Adibi M, Matin SF, Dahmen AS, Spiess PE, Pettaway CA. Robotic or open superficial inguinal lymph node dissection as staging procedures for clinically node negative high risk penile cancer. Urol Oncol. 2024 04; 42(4):120.e1-120.e9. PMID: 38388244.
      Citations:    Fields:    Translation:Humans
    9. Hensley PJ, Labbate C, Zganjar A, Howard J, Huelster H, Durdin T, Pham J, Xiao L, Pallauf M, Lombardo K, Glezerman I, Singla N, Raman JD, Coleman J, Spiess PE, Margulis V, Potretzke AM, Matin SF. Development and Validation of a Multivariable Nomogram Predictive of Post-Nephroureterectomy Renal Function. Eur Urol Oncol. 2024 Feb 01. PMID: 38307832.
      Citations:    Fields:    
    10. Abel EJ, Master VA, Spiess PE, Raman JD, Shapiro DD, Sexton WJ, Zemp L, Patil D, Lauer K, Allen GO, Matin SF, Karam JA. Reply to Eduard Roussel, Riccardo Bertolo, Chiara Ciccarese, et al's Letter to the Editor re: E. Jason Abel, Viraj A. Master, Philippe E. Spiess, et al. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2023;6:266-274. Eur Urol Oncol. 2024 Apr; 7(2):302-303. PMID: 38000932.
      Citations:    Fields:    Translation:Humans
    11. Alhalabi O, Wilson N, Xiao L, Lin Y, Khandelwal J, Moussa MJ, Msaouel P, Navai N, Gao J, Kamat AM, Pilie P, Shah AY, Goswami S, Matin S, Kovitz C, Holla V, Guo C, Czerniak B, Logothetis C, Corn PG, Dinney CPN, Campbell MT, Hansel DE, Tannir NM, Siefker-Radtke AO. Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract. Eur Urol Oncol. 2023 12; 6(6):611-620. PMID: 37833193.
      Citations:    Fields:    Translation:Humans
    12. Singh J, Wang L, Smith TG, Graber W, Matin S, Pisters L, Lenaine Westney O. Ileal Interposition for Ureteral Reconstruction Following Treatment for Abdominopelvic Malignancy: Complications and Outcomes From a Comprehensive Cancer Center. Urology. 2024 01; 183:215-220. PMID: 37802194.
      Citations:    Fields:    Translation:Humans
    13. Abdelsalam ME, Hudspeth TN, Leonards L, Kusin SB, Buckley JR, Bassett R, Awad A, Karam JA, Matin SF, Lu T, Ahrar K. Effectiveness of Thermal Ablation for Renal Cell Carcinoma after Prior Partial Nephrectomy. Eur Urol Open Sci. 2023 Nov; 57:45-50. PMID: 38020520; PMCID: PMC10658406.
      Citations:    
    14. Esdaille AR, Karam JA, Master VA, Spiess PE, Raman JD, Sharma P, Shapiro DD, Das A, Sexton WJ, Zemp L, Patil D, Allen GO, Matin SF, Wood CG, Abel EJ. Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive Patients. Urology. 2023 12; 182:168-174. PMID: 37690543.
      Citations:    Fields:    Translation:Humans
    15. Linehan J, Gottlieb J, Woldu SL, Labbate C, Rose K, Sexton W, Kaimakliotis H, Jacob J, Dickstein R, Nieder A, Bjurlin M, Humphreys M, Ghodoussipour S, Quek M, O'Donnell M, Eisner BH, Feldman AS, Matin SF, Lotan Y, Murray KS. Corrigendum to "Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes" [Eur. Urol. Focus (2023)]. Eur Urol Focus. 2024 Jan; 10(1):211. PMID: 37640582.
      Citations:    Fields:    
    16. Jacob JM, Woldu SL, Linehan J, Labbate C, Rose KM, Sexton WJ, Tachibana I, Kaimakliotis H, Nieder A, Bjurlin MA, Humphreys M, Quek ML, Johnson B, O'Donnell M, Eisner BH, Feldman AS, Murray KS, Matin SF, Lotan Y, Dickstein RJ, Ghodoussipour SB. First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral tumors. Urol Oncol. 2024 01; 42(1):20.e17-20.e23. PMID: 37517898.
      Citations:    Fields:    Translation:Humans
    17. Abel EJ, Master VA, Spiess PE, Raman JD, Shapiro DD, Sexton WJ, Zemp L, Patil D, Lauer K, Allen GO, Matin SF, Karam JA. The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. Eur Urol Oncol. 2024 Apr; 7(2):266-274. PMID: 37442673.
      Citations: 1     Fields:    Translation:Humans
    18. Shapiro DD, Karam JA, Master VA, Sexton WJ, Matin SF, Spiess PE, Abel EJ. Re: Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604-610. Eur Urol Oncol. 2023 12; 6(6):638-639. PMID: 37268448.
      Citations:    Fields:    Translation:Humans
    19. Linehan J, Gottlieb J, Woldu SL, Labbate C, Rose K, Sexton W, Kaimakliotis H, Jacob J, Dickstein R, Nieder A, Bjurlin M, Humphreys M, Ghodoussipor S, Quek M, O'Donnell M, Eisner BH, Feldman AS, Matin SF, Lotan Y, Murray KS. Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes. Eur Urol Focus. 2023 11; 9(6):1052-1058. PMID: 37263827.
      Citations: 2     Fields:    Translation:Humans
    20. Kaimakliotis HZ, Tachibana I, Woldu S, Labbate C, Jacob J, Murray K, Rose K, Sexton W, Dickstein R, Linehan J, Nieder A, Bjurlin M, Humphreys M, Quek M, O'Donnell M, Eisner BH, Matin SF, Lotan Y, Feldman AS, Ghodoussipour S. The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinoma. Urol Oncol. 2023 09; 41(9):387.e1-387.e7. PMID: 37246135.
      Citations: 1     Fields:    Translation:Humans
    21. Karam JA, Msaouel P, Haymaker CL, Matin SF, Campbell MT, Zurita AJ, Shah AY, Wistuba II, Marmonti E, Duose DY, Parra ER, Soto LMS, Laberiano-Fernandez C, Lozano M, Abraham A, Hallin M, Chin CD, Olson P, Der-Torossian H, Yan X, Tannir NM, Wood CG. Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma. Nat Commun. 2023 05 10; 14(1):2684. PMID: 37164948; PMCID: PMC10172300.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    22. Shapiro DD, Karam JA, Master VA, Zemp LW, Sexton WJ, Matin SF, Spiess PE, Jason Abel E. Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6. Eur Urol. 2023 08; 84(2):e55-e56. PMID: 37149462.
      Citations:    Fields:    Translation:Humans
    23. Coleman JA, Clark PE, Bixler BR, Buckley DI, Chang SS, Chou R, Hoffman-Censits J, Kulkarni GS, Matin SF, Pierorazio PM, Potretzke AM, Psutka SP, Raman JD, Smith AB, Smith L. Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline. J Urol. 2023 06; 209(6):1071-1081. PMID: 37096584.
      Citations: 8     Fields:    Translation:Humans
    24. Rose KM, Murray KS, Labbate C, Woldu S, Linehan J, Jacob J, Kaimakliotis H, Dickstein R, Feldman A, Matin SF, Lotan Y, Humphreys MR, Sexton WJ. Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade Disease. Eur Urol Focus. 2023 09; 9(5):807-812. PMID: 37059620.
      Citations: 1     Fields:    
    25. Shapiro DD, Karam JA, Zemp L, Master VA, Sexton WJ, Ghasemzadeh A, Schmeusser BN, Davaro F, Peak T, Patil D, Matin S, Spiess PE, Abel EJ. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci. 2023 Apr; 50:43-46. PMID: 36861106; PMCID: PMC9969293.
      Citations: 1     
    26. Lange SM, Matin SF. EDITORIAL COMMENT. Urology. 2023 02; 172:155-156. PMID: 36773986.
      Citations:    Fields:    
    27. Abdelsalam ME, Awad A, Baiomy A, Irwin D, Karam JA, Matin SF, Sheth RA, Habibollahi P, Odisio BC, Lu T, Ahrar K. Outcomes of Radiofrequency Ablation for Solitary T1a Renal Cell Carcinoma: A 20-Year Tertiary Cancer Center Experience. Cancers (Basel). 2023 Jan 31; 15(3). PMID: 36765867; PMCID: PMC9913388.
      Citations: 1     
    28. Mertens LS, Sharma V, Matin SF, Boorjian SA, Houston Thompson R, van Rhijn BWG, Masson-Lecomte A. Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies. Eur Urol Open Sci. 2023 Mar; 49:60-66. PMID: 36793750; PMCID: PMC9922921.
      Citations: 2     
    29. Labbate C, Woldu S, Murray K, Rose K, Sexton W, Tachibana I, Kaimakliotis H, Jacob J, Dickstein R, Linehan J, Nieder A, Bjurlin M, Humphreys M, Quek M, O'Donnell M, Eisner B, Feldman A, Lotan Y, Matin SF, Ghodoussipour S. Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma. J Urol. 2023 05; 209(5):872-881. PMID: 36657029.
      Citations: 2     Fields:    Translation:Humans
    30. Lange S, Calleris G, Matin SF, Roupr?t M. Optimizing Lymph Node Dissection at the Time of Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma. Eur Urol Focus. 2023 03; 9(2):280-282. PMID: 36642620.
      Citations:    Fields:    Translation:Humans
    31. Woldu SL, Labbate C, Murray KS, Rose K, Sexton W, Tachibana I, Kaimakliotis H, Jacob J, Dickstein R, Linehan J, Nieder A, Bjurlin MA, Humphreys M, Ghodoussipour S, Quek ML, O'Donnell M, Eisner BH, Feldman AS, Matin SF, Lotan Y. Early experience with UGN-101 for the treatment of upper tract urothelial cancer - A multicenter evaluation of practice patterns and outcomes. Urol Oncol. 2023 03; 41(3):147.e15-147.e21. PMID: 36424224.
      Citations:    Fields:    Translation:Humans
    32. Westerman ME, Bree KK, Msaouel P, Kukreja JB, Mantaring C, Rukundo I, Gonzalez MG, Gregg JR, Casteel KN, Matin SF. Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis: A Prospective Quality Improvement Study. J Urol. 2022 10; 208(4):886-895. PMID: 36082549.
      Citations:    
    33. Labbate CV, Hensley PJ, Miest TS, Qiao W, Adibi M, Shah AY, Chery L, Papadopoulos J, Siefker-Radtke AO, Gao J, Guo CC, Czerniak BA, Navai N, Kamat AM, Dinney CP, Campbell MT, Matin SF. Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma. Urol Oncol. 2022 10; 40(10):454.e17-454.e23. PMID: 35961847.
      Citations:    
    34. Labbate CV, Adibi M, Matin SF. Editorial Comment. J Urol. 2022 06; 207(6):1309-1310. PMID: 35236102.
      Citations: 1     Fields:    
    35. Westerman ME, Yevich SM, Dori Y, Ward JF, Pisters LL, Karam JA, Wood CG, Avritscher R, Matin SF. Lymphangioembolization for iatrogenic chylous ascites after retroperitoneal urological surgery. BJU Int. 2022 05; 129(5):585-587. PMID: 34962705.
      Citations:    Fields:    Translation:Humans
    36. Pieretti AC, Ozambela M, Westerman ME, Nogueras-Gonzalez GM, Segarra LA, Zacharias NM, Vaporciyan A, Hofstetter W, Huynh T, Aldousari S, Matin SF, Karam JA. Predictors of Survival in Patients Undergoing Surgery for Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus. Clin Genitourin Cancer. 2022 08; 20(4):e330-e338. PMID: 35279419; PMCID: PMC9486579.
      Citations:    Fields:    Translation:Humans
    37. Matin SF, Pierorazio PM, Kleinmann N, Gore JL, Shabsigh A, Hu B, Chamie K, Godoy G, Hubosky SG, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Seltzer E, Schoenberg M, Lerner SP. Reply by Authors. J Urol. 2022 04; 207(4):788. PMID: 34985341.
      Citations:    Fields:    
    38. Adibi M, McCormick B, Economides MP, Petros F, Xiao L, Guo C, Shah A, Kamat AM, Dinney C, Navai N, Gao J, Siefker-Radtke A, Matin SF, Campbell MT. Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma. Clin Genitourin Cancer. 2022 04; 20(2):176-182. PMID: 35039231.
      Citations:    Fields:    Translation:Humans
    39. Matin SF, Pierorazio PM, Kleinmann N, Gore JL, Shabsigh A, Hu B, Chamie K, Godoy G, Hubosky SG, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Seltzer E, Schoenberg M, Lerner SP. Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report. J Urol. 2022 Apr; 207(4):779-788. PMID: 34915741.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    40. Campbell MT, Matin SF, Tam AL, Sheth RA, Ahrar K, Tidwell RS, Rao P, Karam JA, Wood CG, Tannir NM, Jonasch E, Gao J, Zurita AJ, Shah AY, Jindal S, Duan F, Basu S, Chen H, Espejo AB, Allison JP, Yadav SS, Sharma P. Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma. Nat Commun. 2021 11 04; 12(1):6375. PMID: 34737281; PMCID: PMC8569213.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    41. Alhalabi O, Campbell MT, Xiao L, Adriazola AC, Wilson NR, Siefker-Radtke AO, Corn PG, Zurita A, Jonasch E, Gao J, Adibi M, Kamat AM, Navai N, Pisters LL, Dinney C, Matin SF, Shah AY. Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinoma. BJUI Compass. 2022 Jan; 3(1):37-44. PMID: 35475152; PMCID: PMC8988842.
      Citations: 2     
    42. Westerman ME, Matin SF. EDITORIAL COMMENT. Urology. 2021 10; 156:160-161. PMID: 34758553.
      Citations:    Fields:    
    43. Karam JA, Puligandla M, Flaherty KT, Uzzo RG, Matin SF, Pins MR, Wood CG, Kane C, Jewett MAS, Kim SE, Dutcher JP, DiPaola RS, Haas NB. Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: post hoc analysis from Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) E2805. BJU Int. 2022 06; 129(6):718-722. PMID: 34480522; PMCID: PMC9423939.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    44. Miest T, Khanna A, Sharma V, Hensley PJ, Campbell R, Thapa P, Zganjar A, Tollefson MK, Thompson RH, Frank I, Karnes RJ, Potretzke A, Matin SF, Murthy PB, Haber GP, Lee B, Boorjian SA. Development and Validation of a Risk-Adapted Scoring Model for Metachronous Upper Tract Urothelial Carcinoma following Radical Cystectomy. J Urol. 2022 Feb; 207(2):284-292. PMID: 34547921.
      Citations:    Fields:    Translation:Humans
    45. Pieretti AC, Shapiro DD, Westerman ME, Hwang H, Wang X, Segarra LA, Campbell MT, Tannir NM, Jonasch E, Matin SF, Wood CG, Karam JA. Tumor diameter response in patients with metastatic clear cell renal cell carcinoma is associated with overall survival. Urol Oncol. 2021 12; 39(12):837.e9-837.e17. PMID: 34551888; PMCID: PMC9486901.
      Citations: 1     Fields:    Translation:Humans
    46. Ghandour RA, Freifeld Y, Cheaib J, Singla N, Meng X, Kenigsberg A, Bagrodia A, Woldu S, Hoffman-Censits J, Enikeev D, Rapoport L, Petros FG, Raman JD, Pierorazio PM, Matin SF, Margulis V. Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma. Urol Oncol. 2021 11; 39(11):788.e15-788.e21. PMID: 34330655.
      Citations:    Fields:    Translation:Humans
    47. De B, Venkatesan AM, Msaouel P, Ghia AJ, Li J, Yeboa DN, Nguyen QN, Bishop AJ, Jonasch E, Shah AY, Campbell MT, Wang J, Zurita-Saavedra AJ, Karam JA, Wood CG, Matin SF, Tannir NM, Tang C. Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation. BJU Int. 2022 05; 129(5):610-620. PMID: 34228889; PMCID: PMC10097479.
      Citations: 1     Fields:    Translation:Humans
    48. Pieretti AC, Westerman ME, Childs A, Millward N, Shapiro DD, Sircar K, Rao P, Jonasch E, Campbell MT, Tannir NM, Matin SF, Wood CG, Karam JA. Sarcomatoid features and lymph node-positive disease in chromophobe renal cell carcinoma. Urol Oncol. 2021 11; 39(11):790.e17-790.e23. PMID: 34301458.
      Citations:    Fields:    Translation:Humans
    49. Sharma V, Miest TS, Chamie K, Matin SF, Boorjian SA, Potretzke AM. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-analysis. Reply. J Urol. 2021 10; 206(4):1072. PMID: 34228501.
      Citations:    Fields:    Translation:Humans
    50. Sharma V, Miest TS, Juvet TS, Toussi A, Packiam V, Chamie K, Matin SF, Boorjian SA, Thompson RH, Frank I, Tollefson MK, Potretzke AM. Reply by Authors. J Urol. 2021 09; 206(3):567. PMID: 34121427.
      Citations:    Fields:    
    51. Miest TS, Matin SF. Editorial Comment. J Urol. 2021 Sep; 206(3):576. PMID: 34105990.
      Citations:    Fields:    
    52. Foerster B, Abufaraj M, Matin SF, Gupta M, Li WM, Clinton T, Mir MC, Schweitzer D, Mari A, Kimura S, Bandini M, Mathieu R, Ku JH, Marcq G, Guruli G, Grabbert M, Czech AK, Muilwijk T, Pycha A, D'Andrea D, Petros FG, Spiess PE, Bivalacqua T, Wu WJ, Krabbe LM, Hendricksen K, Egawa S, Briganti A, Moschini M, Graffeille V, Kassouf W, Autorino R, Heidenreich A, Chlosta P, Joniau S, Soria F, Pierorazio PM, Shariat SF, Azizi M, Seisen T, Xylinas E, Roupr?t M. Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study. Eur Urol. 2021 10; 80(4):507-515. PMID: 34023164.
      Citations: 1     Fields:    Translation:Humans
    53. Pisters PW, Ranasinghe W, Wei W, Wood CG, Matin SF, Ward JF, Pisters LL. Long-term renal functional outcomes following ureteroureterostomy performed during multi-organ resection for non-urothelial cancers. BJUI Compass. 2021 Sep; 2(5):348-354. PMID: 35474874; PMCID: PMC8988638.
      Citations: 2     
    54. McIntosh AG, Umbreit EC, Wood CG, Matin SF, Karam JA. Role of lymph node dissection at the time of open or minimally invasive nephroureterectomy. Transl Androl Urol. 2021 May; 10(5):2233-2245. PMID: 34159106; PMCID: PMC8185683.
      Citations:    
    55. Sharma V, Miest TS, Juvet TS, Toussi A, Packiam V, Chamie K, Matin SF, Boorjian SA, Thompson RH, Frank I, Tollefson MK, Potretzke AM. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis. J Urol. 2021 Sep; 206(3):558-567. PMID: 33908802.
      Citations: 3     Fields:    Translation:Humans
    56. Abdelsalam ME, Sabir SH, Ba SBK, Karam JA, Matin SF, Wood CG, Ahrar K. Outcomes of Percutaneous Thermal Ablation for Biopsy-Proven T1a Renal Cell Carcinoma in Patients With Other Primary Malignancies. AJR Am J Roentgenol. 2021 07; 217(1):157-163. PMID: 33909469.
      Citations:    Fields:    Translation:Humans
    57. Petros FG, Choi W, Qi Y, Moss T, Li R, Su X, Guo CC, Czerniak B, Dinney C, McConkey DJ, Matin SF. Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma. J Urol. 2021 09; 206(3):548-557. PMID: 33881933.
      Citations: 3     Fields:    Translation:Humans
    58. Marcq G, Foerster B, Abufaraj M, Matin SF, Gupta M, Li WM, Clinton T, Xylinas E, Mir MC, Schweitzer D, Mari A, Kimura S, Bandini M, Mathieu R, Ku JH, Guruli G, Grabbert M, Czech AK, Muilwijk T, Pycha A, D'Andrea D, Petros FG, Spiess PE, Bivalacqua T, Wu WJ, Krabbe LM, Hendricksen K, Egawa S, Briganti A, Moschini M, Graffeille V, Autorino R, John P, Heidenreich A, Chlosta P, Joniau S, Soria F, Pierorazio PM, Shariat SF, Kassouf W, Azizi M, Seisen T, Roupr?t M. Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study. Eur Urol Focus. 2022 03; 8(2):491-497. PMID: 33773965.
      Citations: 2     Fields:    Translation:Humans
    59. Altok M, Chapin BF, Matin SF, Achim MF, Gregg JR, Davis JW. Therapeutic Consequences of Omitting a Pelvic Lymph Node Dissection at Radical Prostatectomy when Grade and/or Stage Increase. Urology. 2021 09; 155:144-151. PMID: 33676955.
      Citations:    Fields:    Translation:Humans
    60. Bree KK, Hensley PJ, Brooks NA, Matulay J, Li R, Nogueras Gonzalez GM, Navai N, Grossman HB, Matin SF, Dinney CPN, Kamat AM. Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer. BJU Int. 2021 11; 128(5):568-574. PMID: 33484074.
      Citations:    Fields:    Translation:Humans
    61. Adibi M, Matin SF. Editorial Comment. J Urol. 2021 04; 205(4):1046. PMID: 33476195.
      Citations:    Fields:    
    62. Sfakianos JP, Gul Z, Shariat SF, Matin SF, Daneshmand S, Plimack E, Lerner S, Pal S, Roupret M. Genetic Differences Between Bladder and Upper Urinary Tract Carcinoma: Implications for Therapy. Eur Urol Oncol. 2021 04; 4(2):170-179. PMID: 33386276.
      Citations: 6     Fields:    Translation:Humans
    63. Chahoud J, Msaouel P, Ross JA, McCormick BZ, Bathala TK, Gao J, Horn R, Xiao L, Sircar K, Campbell MT, Shah AY, Goswami S, Zurita AJ, Jonasch E, Matin SF, Wood CG, Karam JA, Sharma P, Tannir NM. Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors. Urol Oncol. 2021 02; 39(2):134.e9-134.e16. PMID: 33187886.
      Citations: 1     Fields:    Translation:Humans
    64. Bree K, Matin SF. EDITORIAL COMMENT. Urology. 2020 11; 145:171. PMID: 33167175.
      Citations:    Fields:    
    65. D'Andrea D, Matin S, Black PC, Petros FG, Zargar H, Dinney CP, Cookson MS, Kassouf W, Dall'Era MA, McGrath JS, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, Sridhar SS, North S, Barocas DA, Lotan Y, Stephenson AJ, van Rhijn BW, Spiess PE, Daneshmand S, Shariat SF. Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma. BJU Int. 2021 05; 127(5):528-537. PMID: 32981193; PMCID: PMC8246716.
      Citations:    Fields:    Translation:Humans
    66. Gao J, Navai N, Alhalabi O, Siefker-Radtke A, Campbell MT, Tidwell RS, Guo CC, Kamat AM, Matin SF, Araujo JC, Shah AY, Msaouel P, Corn P, Wang J, Papadopoulos JN, Yadav SS, Blando JM, Duan F, Basu S, Liu W, Shen Y, Zhang Y, Macaluso MD, Wang Y, Chen J, Zhang J, Futreal A, Dinney C, Allison JP, Goswami S, Sharma P. Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma. Nat Med. 2020 12; 26(12):1845-1851. PMID: 33046869; PMCID: PMC9768836.
      Citations: 41     Fields:    Translation:HumansCTClinical Trials
    67. Westerman ME, Shapiro DD, Tannir NM, Campbell MT, Matin SF, Karam JA, Wood CG. Survival following cytoreductive nephrectomy: a comparison of existing prognostic models. BJU Int. 2020 12; 126(6):745-753. PMID: 32623821.
      Citations: 3     Fields:    Translation:Humans
    68. Geiger S, Kocher N, Illinsky D, Xylinas E, Chang P, Dewey L, Wagner AA, Petros F, Matin SF, Tobert C, Tracy C, Patard PM, Roumiguie M, Monteiro LL, Kassouf W, Raman JD. Comparison of the Comprehensive Complication Index and Clavien-Dindo systems in predicting perioperative outcomes following radical nephroureterectomy. Transl Androl Urol. 2020 Aug; 9(4):1780-1785. PMID: 32944540; PMCID: PMC7475662.
      Citations: 1     
    69. Kocher NJ, Canes D, Bensalah K, Roupret M, Lallas C, Margulis V, Shariat S, Colin P, Matin S, Tracy C, Xylinas E, Wagner A, Roumiguie M, Kassouf W, Klatte T, Raman JD. Incidence and preoperative predictors for major complications following radical nephroureterectomy. Transl Androl Urol. 2020 Aug; 9(4):1786-1793. PMID: 32944541; PMCID: PMC7475660.
      Citations: 2     
    70. Freifeld Y, Ghandour R, Singla N, Woldu S, Bagrodia A, Lotan Y, Rapoport LM, Gazimiev M, Delafuente K, Kulangara R, Robyak H, Petros FG, Raman JD, Matin SF, Margulis V. Intraoperative prophylactic intravesical chemotherapy to reduce bladder recurrence following radical nephroureterectomy. Urol Oncol. 2020 09; 38(9):737.e11-737.e16. PMID: 32641241.
      Citations: 1     Fields:    Translation:Humans
    71. Kokorovic A, Matin SF. UGN-101 (mitomycin gel): a novel treatment for low-grade upper tract urothelial carcinoma. Ther Adv Med Oncol. 2020; 12:1758835920937950. PMID: 32670424; PMCID: PMC7339071.
      Citations: 1     
    72. Geynisman DM, Kadow BT, Shuch BM, Boorjian SA, Matin SF, Rampersaud E, Milestone BN, Plimack ER, Zibelman MR, Kutikov A, Smaldone MC, Chen DY, Viterbo R, Joshi S, Greenberg RE, Malizzia L, McGowan T, Ross EA, Uzzo RG. Reply by Authors. J Urol. 2020 09; 204(3):536-537. PMID: 32574522.
      Citations:    Fields:    
    73. Hassler MR, Bray F, Catto JWF, Grollman AP, Margulis V, Matin SF, Sfakianos JP, Shariat SF, Faltas BM, Hartmann A, Roupret M. Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature. Eur Urol. 2020 08; 78(2):209-220. PMID: 32571725.
      Citations: 21     Fields:    Translation:Humans
    74. D'Andrea D, Foerster B, Matin SF, Ku JH, Muilwijk T, Monteiro LL, Liao R, Petros FG, Spiess PE, Bivalacqua TJ, Hendricksen K, van Rhijn BWG, Shabsigh A, Briganti A, Joniau S, Kassouf W, Pierorazio PM, Margulis V, Necchi A, Shariat SF, UTUC collaboration. Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer. Eur Urol Open Sci. 2020 Jul; 19:16-19. PMID: 34337449; PMCID: PMC8317786.
      Citations: 1     
    75. Loloi J, Shingleton WB, Nakada SY, Zagoria RJ, Landman J, Lee BR, Matin SF, Ahrar K, Leveillee RJ, Cadeddu JA, Raman JD. Management of Residual or Recurrent Disease Following Thermal Ablation of Renal Cortical Tumors. J Kidney Cancer VHL. 2020 Jun; 7(2):1-5. PMID: 32665886; PMCID: PMC7331942.
      Citations:    
    76. McIntosh AG, Umbreit EC, Holland LC, Gu C, Tannir NM, Matin SF, Karam JA, Culp SH, Wood CG. Optimizing patient selection for cytoreductive nephrectomy based on outcomes in the contemporary era of systemic therapy. Cancer. 2020 09 01; 126(17):3950-3960. PMID: 32515845.
      Citations: 7     Fields:    Translation:HumansCellsCTClinical Trials
    77. Singla N, Christie A, Freifeld Y, Ghandour RA, Woldu SL, Clinton TN, Petros FG, Robyak H, Yeh HC, Fang D, Enikeev D, Bagrodia A, Sagalowsky AI, Lotan Y, Raman JD, Matin SF, Margulis V. Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinoma. Urol Oncol. 2020 12; 38(12):933.e7-933.e12. PMID: 32430254; PMCID: PMC10676742.
      Citations:    Fields:    Translation:Humans
    78. Kleinmann N, Matin SF, Pierorazio PM, Gore JL, Shabsigh A, Hu B, Chamie K, Godoy G, Hubosky S, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Stern J, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Adibi M, Amin MB, Seltzer E, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Schoenberg M, Lerner SP. Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial. Lancet Oncol. 2020 06; 21(6):776-785. PMID: 32631491.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    79. Geynisman DM, Kadow BT, Shuch BM, Boorjian SA, Matin SF, Rampersaud E, Milestone BN, Plimack ER, Zibelman MR, Kutikov A, Smaldone MC, Chen DY, Viterbo R, Joshi S, Greenberg RE, Malizzia L, McGowan T, Ross EA, Uzzo RG. Sporadic Angiomyolipomas Growth Kinetics While on Everolimus: Results of a Phase II Trial. J Urol. 2020 Sep; 204(3):531-537. PMID: 32250730; PMCID: PMC7695484.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    80. Margulis V, Puligandla M, Trabulsi EJ, Plimack ER, Kessler ER, Matin SF, Godoy G, Alva A, Hahn NM, Carducci MA, Hoffman-Censits J, Collaborators. Reply by Authors. J Urol. 2020 04; 203(4):697-698. PMID: 31967495.
      Citations:    Fields:    
    81. Grant SR, Lei X, Hess KR, Smith GL, Matin SF, Wood CG, Nguyen Q, Frank SJ, Anscher MS, Smith BD, Karam JA, Tang C. Stereotactic Body Radiation Therapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison With Surgery, Tumor Ablation, and Observation. Adv Radiat Oncol. 2020 May-Jun; 5(3):495-502. PMID: 32529146; PMCID: PMC7276675.
      Citations: 2     
    82. Foerster B, Abufaraj M, Petros F, Azizi M, Gupta M, Schweitzer D, Margulis V, Iwata T, Kimura S, Shabsigh A, Briganti A, Ku JH, Muilwijk T, Kassouf W, Matin SF, Spiess PE, Pierorazio PM, Hendricksen K, Shariat SF, UTUC Collaboration. Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial Carcinoma. J Urol. 2020 06; 203(6):1101-1108. PMID: 31898919.
      Citations: 9     Fields:    Translation:Humans
    83. Margulis V, Puligandla M, Trabulsi EJ, Plimack ER, Kessler ER, Matin SF, Godoy G, Alva A, Hahn NM, Carducci MA, Hoffman-Censits J, Collaborators. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma. J Urol. 2020 04; 203(4):690-698. PMID: 31702432; PMCID: PMC7735436.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    84. Borregales LD, Adibi M, Thomas AZ, Reis RB, Chery LJ, Devine CE, Wang X, Potretzke AM, Potretzke T, Figenshau RS, Bauman TM, Aboshady YI, Abel EJ, Matin SF, Karam JA, Wood CG. Predicting Adherent Perinephric Fat Using Preoperative Clinical and Radiological Factors in Patients Undergoing Partial Nephrectomy. Eur Urol Focus. 2021 03; 7(2):397-403. PMID: 31685445.
      Citations: 4     Fields:    Translation:Humans
    85. Altok M, Troncoso P, Achim MF, Matin SF, Gonzalez GN, Davis JW. Prostate cancer upgrading or downgrading of biopsy Gleason scores at radical prostatectomy: prediction of "regression to the mean" using routine clinical features with correlating biochemical relapse rates. Asian J Androl. 2019 Nov-Dec; 21(6):598-604. PMID: 31115364; PMCID: PMC6859655.
      Citations: 2     Fields:    Translation:Humans
    86. Stamatakis L, Matin SF. EDITORIAL COMMENT. Urology. 2019 10; 132:74. PMID: 31582000.
      Citations:    Fields:    Translation:Humans
    87. Freifeld Y, Ghandour R, Singla N, Woldu S, Clinton T, Kulangara R, Bagrodia A, Matin SF, Petros FG, Raman JD, Robyak H, Yan J, Zhu H, Rapoport L, Lotan Y, Margulis V. Preoperative predictive model and nomogram for disease recurrence following radical nephroureterectomy for high grade upper tract urothelial carcinoma. Urol Oncol. 2019 10; 37(10):758-764. PMID: 31378586.
      Citations: 7     Fields:    Translation:Humans
    88. Robinson BD, Vlachostergios PJ, Bhinder B, Liu W, Li K, Moss TJ, Bareja R, Park K, Tavassoli P, Cyrta J, Tagawa ST, Nanus DM, Beltran H, Molina AM, Khani F, Miguel Mosquera J, Xylinas E, Shariat SF, Scherr DS, Rubin MA, Lerner SP, Matin SF, Elemento O, Faltas BM. Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling. Nat Commun. 2019 07 05; 10(1):2977. PMID: 31278255; PMCID: PMC6611775.
      Citations: 45     Fields:    Translation:HumansCells
    89. Lim A, Rao P, Matin SF. Lynch syndrome and urologic malignancies: a contemporary review. Curr Opin Urol. 2019 07; 29(4):357-363. PMID: 31045926.
      Citations: 3     Fields:    Translation:HumansCells
    90. Ruiz-Cordero R, Rao P, Li L, Qi Y, Atherton D, Peng B, Singh RR, Kim TB, Kawakami F, Routbort MJ, Alouch N, Chow CB, Tang X, Lu W, Brimo F, Matin SF, Wood CG, Tannir NM, Wistuba II, Chen K, Wang J, Medeiros LJ, Karam JA, Tamboli P, Sircar K. Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma. Mod Pathol. 2019 11; 32(11):1698-1707. PMID: 31231128.
      Citations: 10     Fields:    Translation:HumansCells
    91. Duplisea JJ, Petros FG, Li R, Fellman B, Guo CC, Czerniak BA, Siefker-Radtke AO, Araujo JC, Dinney CPN, Matin SF. Outcomes of nonmetastatic micropapillary variant upper tract urothelial carcinoma. Urol Oncol. 2019 06; 37(6):354.e19-354.e26. PMID: 30777393; PMCID: PMC6511295.
      Citations: 3     Fields:    Translation:Humans
    92. Petros FG, Qiao W, Singla N, Clinton TN, Robyak H, Raman JD, Margulis V, Matin SF. Preoperative multiplex nomogram for prediction of high-risk nonorgan-confined upper-tract urothelial carcinoma. Urol Oncol. 2019 04; 37(4):292.e1-292.e9. PMID: 30584035.
      Citations: 7     Fields:    Translation:Humans
    93. Yu KJ, Keskin SK, Meissner MA, Petros FG, Wang X, Borregales LD, Gu C, Tamboli P, Matin SF, Wood CG, Karam JA. Renal cell carcinoma and pathologic nodal disease: Implications for American Joint Committee on Cancer staging. Cancer. 2018 10 15; 124(20):4023-4031. PMID: 30276798.
      Citations: 10     Fields:    Translation:Humans
    94. Jonasch E, McCutcheon IE, Gombos DS, Ahrar K, Perrier ND, Liu D, Robichaux CC, Villarreal MF, Weldon JA, Woodson AH, Pilie PG, Fuller GN, Waguespack SG, Matin SF. Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial. Lancet Oncol. 2018 10; 19(10):1351-1359. PMID: 30236511; PMCID: PMC6338228.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    95. Zhang J, Ye Y, Chang DW, Lin SH, Huang M, Tannir NM, Matin S, Karam JA, Wood CG, Chen ZN, Wu X. Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to both Tumorigenesis and Recurrence. Am J Pathol. 2018 11; 188(11):2487-2496. PMID: 30201497; PMCID: PMC6207099.
      Citations: 16     Fields:    Translation:Humans
    96. Peyton CC, Abel EJ, Chipollini J, Boulware DC, Azizi M, Karam JA, Margulis V, Master VA, Matin SF, Raman JD, Sexton WJ, Wood CG, Spiess PE. The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy. Eur Urol Focus. 2020 01 15; 6(1):104-111. PMID: 30206003; PMCID: PMC7771285.
      Citations: 6     Fields:    Translation:HumansCells
    97. Petros FG, Venkatesan AM, Kaya D, Ng CS, Fellman BM, Karam JA, Wood CG, Matin SF. Conditional survival of patients with small renal masses undergoing active surveillance. BJU Int. 2019 03; 123(3):447-455. PMID: 30007044.
      Citations: 2     Fields:    Translation:Humans
    98. Farnum JA, Vikram R, Rao A, Bedi D, Dinney CP, Matin SF. Accuracy of High-Frequency Endoluminal Ultrasonography for Clinical Staging of Upper Tract Urothelial Carcinoma. J Endourol. 2018 09 12; 32(9):806-811. PMID: 30014707.
      Citations:    Fields:    Translation:Humans
    99. Marconi L, de Bruijn R, van Werkhoven E, Beisland C, Fife K, Heidenreich A, Kapoor A, Karam J, Kauffmann C, Klatte T, Matin S, Sjoberg D, Staehler M, Stewart GD, Tanguay S, Uzzo R, Welsh S, Wood L, Wood C, Bex A, Ljungberg B. External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. World J Urol. 2018 Dec; 36(12):1973-1980. PMID: 30069581.
      Citations: 5     Fields:    Translation:Humans
    100. Huang D, Matin SF, Lawrentschuk N, Roupret M. Systematic Review: An Update on the Spectrum of Urological Malignancies in Lynch Syndrome. Bladder Cancer. 2018 Jul 30; 4(3):261-268. PMID: 30112437; PMCID: PMC6087433.
      Citations: 7     
    101. Matin SF, Coleman JA. Misclassification of Upper Tract Urothelial Carcinoma in Patients With Lynch Syndrome. JAMA Oncol. 2018 07 01; 4(7):1010. PMID: 29710233.
      Citations: 1     Fields:    Translation:Humans
    102. Shu X, Gu J, Huang M, Tannir NM, Matin SF, Karam JA, Wood CG, Wu X, Ye Y. Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome. Carcinogenesis. 2018 05 28; 39(6):752-757. PMID: 29635281; PMCID: PMC5972595.
      Citations: 8     Fields:    Translation:Humans
    103. Balasubramanian A, Metcalfe MJ, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SF. Salvage topical therapy for upper tract urothelial carcinoma. World J Urol. 2018 Dec; 36(12):2027-2034. PMID: 29804202; PMCID: PMC6261784.
      Citations: 1     Fields:    Translation:Humans
    104. Hasanov E, Matin SF, Woodson AHH, Marcott VD, Bird S, Slack RS, Fuller GN, McCutcheon IE, Jonasch E, Pili? P. Pilot study of dovitinib in patients with von Hippel-Lindau disease. Oncotarget. 2018 May 04; 9(34):23390-23395. PMID: 29805741; PMCID: PMC5955100.
      Citations: 5     Fields:    
    105. Altok M, Babaian K, Achim MF, Achim GC, Troncoso P, Matin SF, Chapin BF, Davis JW. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection. BJU Int. 2018 07; 122(1):66-75. PMID: 29446205.
      Citations: 4     Fields:    Translation:Humans
    106. Petros FG, Keskin SK, Yu KJ, Li R, Metcalfe MJ, Fellman BM, Chang CM, Gu C, Tamboli P, Matin SF, Karam JA, Wood CG. Intraoperative Conversion From Partial to Radical Nephrectomy: Incidence, Predictive Factors, and Outcomes. Urology. 2018 Jun; 116:114-119. PMID: 29578041.
      Citations: 7     Fields:    Translation:Humans
    107. Petros FG, Metcalfe MJ, Yu KJ, Keskin SK, Fellman BM, Chang CM, Gu C, Tamboli P, Matin SF, Karam JA, Wood CG. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience. World J Urol. 2018 Jul; 36(7):1093-1101. PMID: 29488096.
      Citations: 9     Fields:    Translation:Humans
    108. Hutchinson R, Rew C, Chen G, Woldu S, Krabbe LM, Meissner M, Sheth K, Singla N, Shakir N, Master VA, Karam JA, Matin SF, Borregales LD, Wood C, Masterson T, Thompson RH, Boorjian SA, Leibovich BC, Abel EJ, Bagrodia A, Margulis V. The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus. Urology. 2018 May; 115:119-124. PMID: 29499258.
      Citations: 7     Fields:    Translation:HumansCells
    109. Petros FG, Li R, Matin SF. Endoscopic Approaches to Upper Tract Urothelial Carcinoma. Urol Clin North Am. 2018 May; 45(2):267-286. PMID: 29650142.
      Citations: 5     Fields:    Translation:Humans
    110. Mir MC, Matin SF, Bex A, Spiess PE, Thompson RH, Grob B, van Poppel H. The role of surgery in the management of metastatic kidney cancer: an evidence-based collaborative review. Minerva Urol Nefrol. 2018 Apr; 70(2):109-125. PMID: 29381020.
      Citations: 1     Fields:    Translation:Humans
    111. Matin SF. Editorial Comment. J Urol. 2018 04; 199(4):938-939. PMID: 29331547.
      Citations:    Fields:    Translation:Humans
    112. Bednarski BK, Slack RS, Katz M, You YN, Papadopolous J, Rodriguez-Bigas MA, Skibber JM, Matin SF, Chang GJ. Assessment of Ileostomy Output Using Telemedicine: A Feasibility Trial. Dis Colon Rectum. 2018 Jan; 61(1):77-83. PMID: 29215474; PMCID: PMC8925310.
      Citations: 9     Fields:    Translation:Humans
    113. Petros FG, Matin SF. Re: Association Between Lymph Node Yield and Survival Among Patients Undergoing Radical Nephroureterectomy for Urothelial Carcinoma of the Upper Tract. Eur Urol. 2018 05; 73(5):811-812. PMID: 29249290.
      Citations:    Fields:    Translation:Humans
    114. Zhu J, Tu H, Matin SF, Tannir NM, Wood CG, Wu X. Glycemic index, glycemic load and carbohydrate intake in association with risk of renal cell carcinoma. Carcinogenesis. 2017 10 26; 38(11):1129-1135. PMID: 28968893; PMCID: PMC5862287.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    115. Chipollini J, Abel EJ, Peyton CC, Boulware DC, Karam JA, Margulis V, Master VA, Zargar-Shoshtari K, Matin SF, Sexton WJ, Raman JD, Wood CG, Spiess PE. Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration. Clin Genitourin Cancer. 2018 04; 16(2):e443-e450. PMID: 29113770; PMCID: PMC7771342.
      Citations: 3     Fields:    Translation:Humans
    116. Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, Nguyen Q, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DA. Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort. BJU Int. 2018 04; 121(4):540-548. PMID: 28941030.
      Citations: 8     Fields:    Translation:Humans
    117. Altok M, Achim MF, Matin SF, Pettaway CA, Chapin BF, Davis JW. A decade of robot-assisted radical prostatectomy training: Time-based metrics and qualitative grading for fellows and residents. Urol Oncol. 2018 01; 36(1):13.e19-13.e25. PMID: 28964658.
      Citations: 2     Fields:    Translation:Humans
    118. Wood EL, Adibi M, Qiao W, Brandt J, Zhang M, Tamboli P, Matin SF, Wood CG, Karam JA. Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses. J Urol. 2018 02; 199(2):393-400. PMID: 28941919.
      Citations: 10     Fields:    Translation:Humans
    119. Sun M, Tong P, Kong W, Dong B, Huang Y, Park IY, Zhou L, Liu XD, Ding Z, Zhang X, Bai S, German P, Powell R, Wang Q, Tong X, Tannir NM, Matin SF, Rathmell WK, Fuller GN, McCutcheon IE, Walker CL, Wang J, Jonasch E. HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas. Cancer Res. 2017 10 01; 77(19):5313-5326. PMID: 28807937; PMCID: PMC5626626.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    120. Metcalfe MJ, Petros FG, Rao P, Mork ME, Xiao L, Broaddus RR, Matin SF. Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma. J Urol. 2018 01; 199(1):60-65. PMID: 28797715.
      Citations: 15     Fields:    Translation:Humans
    121. Metcalfe M, Wagenheim G, Xiao L, Papadopoulos J, Navai N, Davis JW, Karam JA, Kamat AM, Wood CG, Dinney CP, Matin SF. Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes. J Endourol. 2017 09; 31(9):946-953. PMID: 28731777; PMCID: PMC5915259.
      Citations: 9     Fields:    Translation:Humans
    122. Moss TJ, Qi Y, Xi L, Peng B, Kim TB, Ezzedine NE, Mosqueda ME, Guo CC, Czerniak BA, Ittmann M, Wheeler DA, Lerner SP, Matin SF. Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma. Eur Urol. 2017 10; 72(4):641-649. PMID: 28601352.
      Citations: 67     Fields:    Translation:Humans
    123. Campbell MT, Shah AY, Matin SF, Siefker-Radtke AO. Optimizing management of upper tract urothelial carcinoma. Urol Oncol. 2017 07; 35(7):492-498. PMID: 28579283.
      Citations: 3     Fields:    Translation:Humans
    124. Matin SF. Editorial Comment. J Urol. 2017 09; 198(3):551. PMID: 28551454.
      Citations:    Fields:    Translation:Humans
    125. Gu J, Herrera LA, Tannir NM, Zhang S, Matin S, Karam JA, Wood CG, Wu X, Mendoza-P?rez J. Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma. Cancer. 2017 Sep 15; 123(18):3617-3627. PMID: 28543182; PMCID: PMC5589484.
      Citations: 13     Fields:    Translation:HumansCells
    126. Keskin SK, Msaouel P, Hess KR, Yu KJ, Matin SF, Sircar K, Tamboli P, Jonasch E, Wood CG, Karam JA, Tannir NM. Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras. J Urol. 2017 09; 198(3):530-537. PMID: 28411072; PMCID: PMC5597336.
      Citations: 20     Fields:    Translation:Humans
    127. Leal I, Milbury K, Engebretson J, Matin S, Jonasch E, Tannir N, Wood CG, Cohen L. Interconnection: A qualitative analysis of adjusting to living with renal cell carcinoma. Palliat Support Care. 2018 04; 16(2):146-154. PMID: 28262086; PMCID: PMC5587362.
      Citations: 2     Fields:    Translation:Humans
    128. Abel EJ, Spiess PE, Margulis V, Master VA, Mann M, Zargar-Shoshtari K, Borregales LD, Sexton WJ, Patil D, Matin SF, Wood CG, Karam JA. Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus. J Urol. 2017 08; 198(2):281-288. PMID: 28268170.
      Citations: 13     Fields:    Translation:Humans
    129. Ferguson JE, Matin SF. Re: Targeting Renal Cell Carcinoma with a HIF-2 Antagonist. Eur Urol. 2017 06; 71(6):987. PMID: 28237787.
      Citations: 1     Fields:    Translation:HumansCells
    130. Kalra S, Verma J, Atkinson BJ, Matin SF, Wood CG, Karam JA, Lin SH, Satcher RL, Tamboli P, Sircar K, Rao P, Corn PG, Tannir NM, Jonasch E. Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era. Clin Genitourin Cancer. 2017 06; 15(3):363-370. PMID: 28216278.
      Citations: 8     Fields:    Translation:Humans
    131. Metcalfe MJ, Matin SF. Editorial Comment. Urology. 2017 Feb; 100:150. PMID: 27993389.
      Citations:    Fields:    
    132. Shah AY, Karam JA, Rao P, Lim ZD, Jonasch E, Xiao L, Gao J, Vaishampayan UN, Heng DY, Plimack ER, Guancial EA, Fung C, Lowas SR, Tamboli P, Sircar K, Matin SF, Kimryn Rathmell W, Wood CG, Tannir NM, Malouf GG. Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study. BJU Int. 2017 12; 120(6):782-792. PMID: 27860149; PMCID: PMC6857178.
      Citations: 22     Fields:    Translation:Humans
    133. Shu X, Hildebrandt MA, Gu J, Tannir NM, Matin SF, Karam JA, Wood CG, Wu X. MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity. Br J Cancer. 2017 01 03; 116(1):77-84. PMID: 27907930; PMCID: PMC5220154.
      Citations: 19     Fields:    Translation:HumansCells
    134. Pini G, Matin SF, Suardi N, Desai M, Gill I, Porter J, Stein RJ, Sotelo R, Gaboardi F, Porpiglia F. Robot assisted lymphadenectomy in urology: pelvic, retroperitoneal and inguinal. Minerva Urol Nefrol. 2017 02; 69(1):38-55. PMID: 28009144; PMCID: PMC9134864.
      Citations: 3     Fields:    Translation:Humans
    135. Gupta N, Patel A, Ensor J, Ahrar K, Ahrar J, Tam A, Odisio B, Huang S, Murthy R, Mahvash A, Avritscher R, McRae S, Sabir S, Wallace M, Matin S, Gupta S. Multiple Renal Artery Pseudoaneurysms in Patients Undergoing Renal Artery Embolization Following Partial Nephrectomy: Correlation with RENAL Nephrometry Scores. Cardiovasc Intervent Radiol. 2017 Feb; 40(2):202-209. PMID: 27681271.
      Citations: 4     Fields:    Translation:Humans
    136. Redrow GP, Guo CC, Brausi MA, Coleman JA, Fernandez MI, Kassouf W, Keeley FX, Margulis V, Raman JD, Shariat SF, Spiess PE, Thalmann GN, Matin SF, Roupret M. Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future Direction. J Urol. 2017 02; 197(2):287-295. PMID: 27664578.
      Citations: 10     Fields:    Translation:Humans
    137. Petros FG, Matin SF. Cryoablation for cT1b Renal Tumors? Yet To Be Determined. Eur Urol. 2017 01; 71(1):118-119. PMID: 27616722.
      Citations: 1     Fields:    Translation:Humans
    138. Matin SF. Kidney cancer: Quality-of-life outcomes in patients with small renal masses. Nat Rev Urol. 2016 08; 13(8):443-4. PMID: 27400666.
      Citations: 2     Fields:    Translation:Humans
    139. Mandalapu RS, Remzi M, de Reijke TM, Margulis V, Palou J, Kapoor A, Yossepowitch O, Coleman J, Anderson JK, Catto J, de la Rosette J, O'Brien T, Zlotta A, Matin SF, Traxer O. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma. World J Urol. 2017 Mar; 35(3):355-365. PMID: 27233780; PMCID: PMC5554604.
      Citations: 13     Fields:    Translation:Humans
    140. Milbury K, Lopez G, Spelman A, Wood C, Matin SF, Tannir NM, Jonasch E, Pisters L, Wei Q, Cohen L. Examination of moderators of expressive writing in patients with renal cell carcinoma: the role of depression and social support. Psychooncology. 2017 09; 26(9):1361-1368. PMID: 27145447; PMCID: PMC5094904.
      Citations: 11     Fields:    Translation:Humans
    141. Sabir S, Ahrar K, Matin SF. Predicting and Determining the Success of Percutaneous Ablation. J Urol. 2016 07; 196(1):7-8. PMID: 27086180.
      Citations:    Fields:    Translation:Humans
    142. Alemozaffar M, Bellmunt J, Bochner BH, Boorjian SA, Daneshmand S, Huang WC, Kondo T, Konety BR, Laguna MP, Matin SF, Siefker-Radtke AO, Shariat SF, Gakis G, Schubert T, Stenzl A. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease. World J Urol. 2017 Mar; 35(3):327-335. PMID: 27043218.
      Citations: 11     Fields:    Translation:Humans
    143. Thomas AZ, Adibi M, Slack RS, Borregales LD, Merrill MM, Tamboli P, Sircar K, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JA. The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation: A Matched Controlled Analysis. J Urol. 2016 Sep; 196(3):678-84. PMID: 27036304; PMCID: PMC5014677.
      Citations: 12     Fields:    Translation:Humans
    144. Redrow GP, Matin SF. Upper tract urothelial carcinoma: epidemiology, high risk populations and detection. Minerva Urol Nefrol. 2016 Aug; 68(4):350-8. PMID: 27008468.
      Citations: 6     Fields:    Translation:Humans
    145. Haas NB, Manola J, Uzzo RG, Flaherty KT, Wood CG, Kane C, Jewett M, Dutcher JP, Atkins MB, Pins M, Wilding G, Cella D, Wagner L, Matin S, Kuzel TM, Sexton WJ, Wong YN, Choueiri TK, Pili R, Puzanov I, Kohli M, Stadler W, Carducci M, Coomes R, DiPaola RS. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet. 2016 May 14; 387(10032):2008-16. PMID: 26969090; PMCID: PMC4878938.
      Citations: 182     Fields:    Translation:HumansCTClinical Trials
    146. Mandalapu RS, Matin SF. Contemporary Evaluation and Management of Upper Tract Urothelial Cancer. Urology. 2016 Aug; 94:17-23. PMID: 26850816.
      Citations: 6     Fields:    Translation:Humans
    147. Katz MH, Slack R, Bruno M, McMillan J, Fleming JB, Lee JE, Bednarski B, Papadopoulos J, Matin SF. Outpatient virtual clinical encounters after complex surgery for cancer: a prospective pilot study of "TeleDischarge". J Surg Res. 2016 May 01; 202(1):196-203. PMID: 27083967.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    148. Matin SF, Melquist J, Karam JA. Author reply. Urology. 2016 Jan; 87:222-3. PMID: 27243090.
      Citations:    Fields:    Translation:Humans
    149. Borregales LD, Kim DY, Staller AL, Qiao W, Thomas AZ, Adibi M, Tamboli P, Sircar K, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JA. Prognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy. Urol Oncol. 2016 May; 34(5):237.e19-26. PMID: 26707613; PMCID: PMC4835261.
      Citations: 4     Fields:    Translation:Humans
    150. Gu J, Tannir NM, Matin SF, Karam JA, Huang M, Chang DW, Wood CG, Wu X, Mendoza-P?rez J, Herrera LA. Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case-Control Study. Clin Cancer Res. 2016 Apr 15; 22(8):2074-82. PMID: 26655847; PMCID: PMC4834236.
      Citations: 12     Fields:    Translation:HumansCells
    151. Tannir NM, Jonasch E, Albiges L, Altinmakas E, Ng CS, Matin SF, Wang X, Qiao W, Dubauskas Lim Z, Tamboli P, Rao P, Sircar K, Karam JA, McDermott DF, Wood CG, Choueiri TK. Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial. Eur Urol. 2016 05; 69(5):866-74. PMID: 26626617; PMCID: PMC4879109.
      Citations: 100     Fields:    Translation:HumansCTClinical Trials
    152. Karam JA, Matin SF. Positive Margins after Radical Nephrectomy with Venous Thrombectomy: Controversies and Treatment Options. J Urol. 2016 Feb; 195(2):241-2. PMID: 26585683.
      Citations:    Fields:    Translation:Humans
    153. Melkonian SC, Daniel CR, Ye Y, Tannir NM, Karam JA, Matin SF, Wood CG, Wu X. Gene-environment interaction of genome-wide association study-identified susceptibility loci and meat-cooking mutagens in the etiology of renal cell carcinoma. Cancer. 2016 Jan 01; 122(1):108-15. PMID: 26551148; PMCID: PMC5016565.
      Citations: 13     Fields:    Translation:Humans
    154. Adibi M, Thomas AZ, Borregales LD, Matin SF, Wood CG, Karam JA. Surgical considerations for patients with metastatic renal cell carcinoma. Urol Oncol. 2015 Dec; 33(12):528-37. PMID: 26546481.
      Citations: 9     Fields:    Translation:Humans
    155. Williams SB, Davis JW, Wang X, Achim MF, Zurita-Saavedra A, Matin SF, Pisters LL, Ward JF, Pettaway CA, Chapin BF. Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity: Contemporary Results Using the Clavien System. Clin Genitourin Cancer. 2016 Apr; 14(2):130-8. PMID: 26558524.
      Citations: 4     Fields:    Translation:Humans
    156. Melquist JJ, Redrow G, Delacroix S, Park A, Faria EE, Karam JA, Matin SF. Comparison of Single-docking Robotic-assisted and Traditional Laparoscopy for Retroperitoneal Lymph Node Dissection During Nephroureterectomy With Bladder Cuff Excision for Upper-tract Urothelial Carcinoma. Urology. 2016 Jan; 87:216-23. PMID: 26494291.
      Citations: 10     Fields:    Translation:Humans
    157. Zhou L, Liu XD, Sun M, Zhang X, German P, Bai S, Ding Z, Tannir N, Wood CG, Matin SF, Karam JA, Tamboli P, Sircar K, Rao P, Rankin EB, Laird DA, Hoang AG, Walker CL, Giaccia AJ, Jonasch E. Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma. Oncogene. 2016 05; 35(21):2687-97. PMID: 26364599; PMCID: PMC4791213.
      Citations: 149     Fields:    Translation:HumansAnimalsCells
    158. McConkey DJ, Choi W, Shen Y, Lee IL, Porten S, Matin SF, Kamat AM, Corn P, Millikan RE, Dinney C, Czerniak B, Siefker-Radtke AO. A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-na?ve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer. Eur Urol. 2016 05; 69(5):855-62. PMID: 26343003; PMCID: PMC4775435.
      Citations: 97     Fields:    Translation:HumansCellsCTClinical Trials
    159. Matin SF, McConkey DJ. Bridging the Gap in Upper Tract Urothelial Carcinoma. Eur Urol. 2015 Dec; 68(6):978-9. PMID: 26298210.
      Citations: 2     Fields:    Translation:Humans
    160. Kalra S, Atkinson BJ, Matrana MR, Matin SF, Wood CG, Karam JA, Tamboli P, Sircar K, Rao P, Corn PG, Tannir NM, Jonasch E. Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases. BJU Int. 2016 May; 117(5):761-5. PMID: 26032863; PMCID: PMC4666814.
      Citations: 26     Fields:    Translation:Humans
    161. Zhou C, Urbauer DL, Fellman BM, Tamboli P, Zhang M, Matin SF, Wood CG, Karam JA. Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre. BJU Int. 2016 May; 117(5):775-82. PMID: 26053895; PMCID: PMC4670601.
      Citations: 21     Fields:    Translation:Humans
    162. Davis JW, Ward JF, Pettaway CA, Wang X, Kuban D, Frank SJ, Lee AK, Pisters LL, Matin SF, Shah JB, Karam JA, Chapin BF, Papadopoulos JN, Achim M, Hoffman KE, Pugh TJ, Choi S, Troncoso P, Logothetis CJ, Kim J. Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int. 2016 07; 118(1):68-76. PMID: 26059275; PMCID: PMC4808616.
      Citations: 17     Fields:    Translation:Humans
    163. Matin SF, Sfakianos JP, Espiritu PN, Coleman JA, Spiess PE. Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates. J Urol. 2015 Dec; 194(6):1567-74. PMID: 26094807; PMCID: PMC4896731.
      Citations: 26     Fields:    Translation:HumansCTClinical Trials
    164. Faria EF, Chapin BF, Muller RL, Machado RD, Reis RB, Matin SF. Radical Prostatectomy for Locally Advanced Prostate Cancer: Current Status. Urology. 2015 Jul; 86(1):10-5. PMID: 26048432.
      Citations: 14     Fields:    Translation:Humans
    165. Liu XD, Hoang A, Zhou L, Kalra S, Yetil A, Sun M, Ding Z, Zhang X, Bai S, German P, Tamboli P, Rao P, Karam JA, Wood C, Matin S, Zurita A, Bex A, Griffioen AW, Gao J, Sharma P, Tannir N, Sircar K, Jonasch E. Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma. Cancer Immunol Res. 2015 Sep; 3(9):1017-29. PMID: 26014097; PMCID: PMC4561186.
      Citations: 77     Fields:    Translation:HumansAnimalsCells
    166. Adibi M, Thomas AZ, Borregales LD, Merrill MM, Slack RS, Chen HC, Sircar K, Murugan P, Tamboli P, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JA. Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation. Urol Oncol. 2015 Oct; 33(10):427.e17-23. PMID: 26004164; PMCID: PMC4584175.
      Citations: 14     Fields:    Translation:Humans
    167. Zargar H, Atwell TD, Cadeddu JA, de la Rosette JJ, Janetschek G, Kaouk JH, Matin SF, Polascik TJ, Zargar-Shoshtari K, Thompson RH. Cryoablation for Small Renal Masses: Selection Criteria, Complications, and Functional and Oncologic Results. Eur Urol. 2016 Jan; 69(1):116-28. PMID: 25819723.
      Citations: 34     Fields:    Translation:Humans
    168. Kenney PA, Vikram R, Prasad SR, Tamboli P, Matin SF, Wood CG, Karam JA. Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: a detailed study of radiological, pathological and clinical outcomes. BJU Int. 2015 Jul; 116(1):85-92. PMID: 25395040.
      Citations: 20     Fields:    Translation:Humans
    169. Thomas AZ, Adibi M, Borregales LD, Hoang LN, Tamboli P, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JA. Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy. J Urol. 2015 Aug; 194(2):316-22. PMID: 25758610; PMCID: PMC4666307.
      Citations: 13     Fields:    Translation:Humans
    170. Mork M, Hubosky SG, Margulis V, Raman J, Lotan Y, O'Brien T, You N, Shariat SF, Matin SF, Roupr?t M. Lynch Syndrome: A Primer for Urologists and Panel Recommendations. J Urol. 2015 Jul; 194(1):21-9. PMID: 25711197.
      Citations: 14     Fields:    Translation:Humans
    171. Thekdi SM, Milbury K, Spelman A, Wei Q, Wood C, Matin SF, Tannir N, Jonasch E, Pisters L, Cohen L. Posttraumatic stress and depressive symptoms in renal cell carcinoma: association with quality of life and utility of single-item distress screening. Psychooncology. 2015 Nov; 24(11):1477-84. PMID: 25690556; PMCID: PMC4539280.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    172. Merrill MM, Wood CG, Tannir NM, Slack RS, Babaian KN, Jonasch E, Pagliaro LC, Compton Z, Tamboli P, Sircar K, Pisters LL, Matin SF, Karam JA. Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent. Urol Oncol. 2015 Apr; 33(4):166.e21-9. PMID: 25700975; PMCID: PMC4664068.
      Citations: 20     Fields:    Translation:Humans
    173. Karam JA, Babaian KN, Tannir NM, Matin SF, Wood CG. Role of partial nephrectomy as cytoreduction in the management of metastatic renal cell carcinoma. Minerva Urol Nefrol. 2015 Jun; 67(2):149-56. PMID: 25645343.
      Citations:    Fields:    Translation:Humans
    174. Karam JA, Wood CG, Compton ZR, Rao P, Vikram R, Ahrar K, Matin SF. Salvage surgery after energy ablation for renal masses. BJU Int. 2015 Jan; 115(1):74-80. PMID: 24656119.
      Citations: 7     Fields:    Translation:Humans
    175. Williams SB, Matin SF, Matin S, Subbarao CD. Implementation of a Very Low Calorie Diet in Patients Undergoing?Urologic Surgery: Room for Improvement? Clin Genitourin Cancer. 2015 Aug; 13(4):e203-e204. PMID: 25604913.
      Citations:    Fields:    Translation:Humans
    176. Melkonian SC, Wang X, Gu J, Matin SF, Tannir NM, Wood CG, Wu X. Mitochondrial DNA copy number in peripheral blood leukocytes and the risk of clear cell renal cell carcinoma. Carcinogenesis. 2015 Feb; 36(2):249-55. PMID: 25524925; PMCID: PMC4322190.
      Citations: 12     Fields:    Translation:HumansCells
    177. Li W, Liang Y, Deavers MT, Kamat AM, Matin SF, Dinney CP, Czerniak B, Guo CC. Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants. Am J Clin Pathol. 2014 Dec; 142(6):864-71. PMID: 25389341.
      Citations: 8     Fields:    Translation:Humans
    178. Navai N, Matin SF. Words of wisdom. Re: A randomized trial of robot-assisted laparoscopic radical cystectomy. Eur Urol. 2015 Jan; 67(1):173-174. PMID: 25528394.
      Citations: 1     Fields:    Translation:Humans
    179. Matin SF. 'Discontent is the first necessity of progress', Thomas A. Edison. BJU Int. 2014 Nov; 114(5):635. PMID: 25339071.
      Citations:    Fields:    Translation:Humans
    180. Babaian KN, Kim DY, Kenney PA, Wood CG, Wong J, Sanchez C, Fang JE, Gerber JA, Didic A, Wahab A, Golla V, Torres C, Tamboli P, Qiao W, Matin SF, Wood CG, Karam JA. Preoperative predictors of pathological lymph node metastasis in patients with renal cell carcinoma undergoing retroperitoneal lymph node dissection. J Urol. 2015 Apr; 193(4):1101-7. PMID: 25390078.
      Citations: 17     Fields:    Translation:Humans
    181. Huang SY, Ahrar K, Gupta S, Wallace MJ, Ensor JE, Krishnamurthy S, Matin SF. Safety and diagnostic accuracy of percutaneous biopsy in upper tract urothelial carcinoma. BJU Int. 2015 Apr; 115(4):625-32. PMID: 24905868.
      Citations: 4     Fields:    Translation:Humans
    182. Choi H, Underwood M, Boonsirikamchai P, Matin S, Troncoso P, Ma J. Technical challenges in 3 T magnetic resonance spectroscopic imaging of the prostate-A single-institution experience. Quant Imaging Med Surg. 2014 Aug; 4(4):251-8. PMID: 25202660; PMCID: PMC4137178.
      Citations: 1     
    183. Apolo AB, Hoffman V, Kaag MG, Latini DM, Lee CT, Rosenberg JE, Knowles M, Theodorescu D, Czerniak BA, Efstathiou JA, Albert ML, Sridhar SS, Margulis V, Matin SF, Galsky MD, Hansel D, Kamat AM, Flaig TW, Smith AB, Messing E, Zipursky Quale D, Lotan Y. Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward. Urol Oncol. 2015 Feb; 33(2):53-64. PMID: 25065704; PMCID: PMC6776416.
      Citations: 4     Fields:    Translation:HumansAnimals
    184. Rao P, Monzon F, Jonasch E, Matin SF, Tamboli P. Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome--clinicopathological features and comparative genomic analysis of 3 cases. Hum Pathol. 2014 Sep; 45(9):1966-72. PMID: 25081542.
      Citations: 13     Fields:    Translation:Humans
    185. Kharadjian TB, Matin SF, Pettaway CA. Early experience of robotic-assisted inguinal lymphadenectomy: review of surgical outcomes relative to alternative approaches. Curr Urol Rep. 2014 Jun; 15(6):412. PMID: 24756453.
      Citations: 8     Fields:    Translation:Humans
    186. Satcher RL, Bogler O, Hyle L, Lee A, Simmons A, Williams R, Hawk E, Matin S, Brewster AM. Telemedicine and telesurgery in cancer care: inaugural conference at MD Anderson Cancer Center. J Surg Oncol. 2014 Sep; 110(4):353-9. PMID: 24889208.
      Citations: 10     Fields:    Translation:Humans
    187. Hamdi A, Mulanovich VE, Matin SF, Landon G, Sircar K, Tu SM, Nieto Y. Isolated renal mucormycosis in a transplantation recipient. J Clin Oncol. 2015 Apr 01; 33(10):e50-1. PMID: 24821884.
      Citations: 2     Fields:    Translation:Humans
    188. Eggener SE, Clark MA, Shikanov S, Smith B, Kaag M, Russo P, Wheat JC, Wolf JS, Matin SF, Huang WC, Harel M, Cambio J, Shalhav AL, Raman JD. Impact of warm versus cold ischemia on renal function following partial nephrectomy. World J Urol. 2015 Mar; 33(3):351-7. PMID: 24817142.
      Citations: 5     Fields:    Translation:Humans
    189. Porten S, Siefker-Radtke AO, Xiao L, Margulis V, Kamat AM, Wood CG, Jonasch E, Dinney CP, Matin SF. Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma. Cancer. 2014 Jun 15; 120(12):1794-9. PMID: 24633966; PMCID: PMC4440575.
      Citations: 54     Fields:    Translation:Humans
    190. Babaian KN, Merrill MM, Matin S, Tamboli P, Tannir NM, Jonasch E, Wood CG, Karam JA. Partial nephrectomy in the setting of metastatic renal cell carcinoma. J Urol. 2014 Jul; 192(1):36-42. PMID: 24518767; PMCID: PMC4502598.
      Citations: 3     Fields:    Translation:Humans
    191. Milbury K, Spelman A, Wood C, Matin SF, Tannir N, Jonasch E, Pisters L, Wei Q, Cohen L. Randomized controlled trial of expressive writing for patients with renal cell carcinoma. J Clin Oncol. 2014 Mar 01; 32(7):663-70. PMID: 24470003; PMCID: PMC3927735.
      Citations: 18     Fields:    Translation:Humans
    192. Matin SF, Shariat SF, Milowsky MI, Hansel DE, Kassouf W, Koppie T, Bajorin D, Grollman AP. Highlights from the first symposium on upper tract urothelial carcinoma. Urol Oncol. 2014 Apr; 32(3):309-16. PMID: 24397995.
      Citations: 1     Fields:    Translation:Humans
    193. Abel EJ, Fisher MB, Matin SF, Kamat AM, Dinney CP, Grossman HB. Delayed ureterectomy after incomplete nephroureterectomy for upper tract urothelial carcinoma: pathologic findings and outcomes. Int Braz J Urol. 2013 Nov-Dec; 39(6):817-22. PMID: 24456786.
      Citations: 1     Fields:    Translation:Humans
    194. Laguna MP. Re: Illness uncertainty and quality of life of patients with small renal tumors undergoing watchful waiting: a 2-year prospective study. J Urol. 2013 Nov; 190(5):1710. PMID: 24120769.
      Citations:    Fields:    Translation:Humans
    195. Chen XP, Xiong GY, Li XS, Matin SF, Garcia M, Fang D, Wang TY, Yu W, Gong K, Song Y, He ZS, He Q, Zhou LQ. Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in China. BJU Int. 2013 Nov; 112(7):917-24. PMID: 23905945.
      Citations: 29     Fields:    Translation:Humans
    196. Matin SF. Accepting the positive results of unconventional methods. BJU Int. 2013 Jul; 112(1):5-6. PMID: 23759004.
      Citations:    Fields:    Translation:Humans
    197. Matin SF. Editorial comment. Urology. 2013 Aug; 82(2):268-9; discussion 269. PMID: 23791216.
      Citations: 1     Fields:    Translation:Humans
    198. Faria EF, Caputo PA, Wood CG, Karam JA, Matin SF, Nogueras-Gonz?lez GM. Robotic partial nephrectomy shortens warm ischemia time, reducing suturing time kinetics even for an experienced laparoscopic surgeon: a comparative analysis. World J Urol. 2014 Feb; 32(1):265-71. PMID: 23783881; PMCID: PMC3874425.
      Citations: 8     Fields:    Translation:Humans
    199. Faria E, Turturro F, Rao P, Matin SF. Malignant epithelioid angiomyolipoma: tumor and metabolic response to everolimus as evaluated with positron emission tomography. Clin Genitourin Cancer. 2013 Dec; 11(4):e1-5. PMID: 23791549; PMCID: PMC3834094.
      Citations: 3     Fields:    Translation:Humans
    200. Ahrar K, Ahrar JU, Javadi S, Pan L, Wood CG, Matin SF, Stafford RJ, Milton DR. Real-time magnetic resonance imaging-guided cryoablation of small renal tumors at 1.5 T. Invest Radiol. 2013 Jun; 48(6):437-44. PMID: 23511191; PMCID: PMC3899798.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    201. Matin SF, Cormier JN, Ward JF, Pisters LL, Wood CG, Dinney CP, Royal RE, Huang X, Pettaway CA. Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma. BJU Int. 2013 Jun; 111(7):1068-74. PMID: 23551693; PMCID: PMC3651805.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    202. Matin SF. Words of wisdom: re: pilot trial of sunitinib therapy in patients with von hippel-lindau disease. Eur Urol. 2013 Apr; 63(4):770. PMID: 23438395.
      Citations: 1     Fields:    
    203. Karam JA, Ahrar K, Vikram R, Romero CA, Jonasch E, Tannir NM, Rao P, Wood CG, Matin SF. Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results. BJU Int. 2013 May; 111(6):997-1005. PMID: 23510233; PMCID: PMC3637414.
      Citations: 5     Fields:    Translation:Humans
    204. Parker PA, Alba F, Fellman B, Urbauer DL, Li Y, Karam JA, Tannir N, Jonasch E, Wood CG, Matin SF. Illness uncertainty and quality of life of patients with small renal tumors undergoing watchful waiting: a 2-year prospective study. Eur Urol. 2013 Jun; 63(6):1122-7. PMID: 23419322; PMCID: PMC3866912.
      Citations: 21     Fields:    Translation:Humans
    205. Matin SF. Editorial comment. J Urol. 2012 Dec; 188(6):2211. PMID: 23083659.
      Citations:    Fields:    Translation:Humans
    206. Green DA, Rink M, Xylinas E, Matin SF, Stenzl A, Roupret M, Karakiewicz PI, Scherr DS, Shariat SF. Urothelial carcinoma of the bladder and the upper tract: disparate twins. J Urol. 2013 Apr; 189(4):1214-21. PMID: 23023150.
      Citations: 94     Fields:    Translation:Humans
    207. Matin SF. Re: Functional recovery after partial nephrectomy: effects of volume loss and ischemic injury: M. N. Simmons, S. P. Hillyer, B. H. Lee, A. F. Fergany, J. Kaouk and S. C. Campbell. J Urol 2012; 187: 1667-1673. J Urol. 2012 Sep; 188(3):1048-9. PMID: 22819102.
      Citations:    Fields:    Translation:Humans
    208. Rink M, Sjoberg D, Comploj E, Margulis V, Xylinas E, Lee RK, Hansen J, Cha EK, Raman JD, Remzi M, Bensalah K, Novara G, Matin SF, Chun FK, Kikuchi E, Kassouf W, Martinez-Salamanca JI, Lotan Y, Seitz C, Pycha A, Zigeuner R, Karakiewicz PI, Scherr DS, Vickers AJ, Shariat SF. Risk of cancer-specific mortality following recurrence after radical nephroureterectomy. Ann Surg Oncol. 2012 Dec; 19(13):4337-44. PMID: 22805867; PMCID: PMC3576920.
      Citations: 11     Fields:    Translation:Humans
    209. Tannir NM, Plimack E, Ng C, Tamboli P, Bekele NB, Xiao L, Smith L, Lim Z, Pagliaro L, Araujo J, Aparicio A, Matin S, Wood CG, Jonasch E. A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma. Eur Urol. 2012 Dec; 62(6):1013-9. PMID: 22771265; PMCID: PMC3882163.
      Citations: 55     Fields:    Translation:HumansCTClinical Trials
    210. Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, Comploj E, Novara G, Margulis V, Raman JD, Lotan Y, Kassouf W, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Zigeuner R, Pycha A, Scherr DS, Seitz C, Walton T, Trinh QD, Karakiewicz PI, Matin S, Montorsi F, Zerbib M, Shariat SF, Upper Tract Urothelial Carcinoma Collaboration. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol. 2014 Jan; 65(1):210-7. PMID: 22579047.
      Citations: 57     Fields:    Translation:Humans
    211. Abel EJ, Carrasco A, Culp SH, Matin SF, Tamboli P, Tannir NM, Wood CG. Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases. BJU Int. 2012 Dec; 110(11):1742-6. PMID: 22503066.
      Citations: 16     Fields:    Translation:Humans
    212. Alva AS, Matin SF, Lerner SP, Siefker-Radtke AO. Perioperative chemotherapy for upper tract urothelial cancer. Nat Rev Urol. 2012 Apr 10; 9(5):266-73. PMID: 22487872.
      Citations: 7     Fields:    Translation:Humans
    213. Smeenge M, Barentsz J, Cosgrove D, de la Rosette J, de Reijke T, Eggener S, Frauscher F, Kovacs G, Matin SF, Mischi M, Pinto P, Rastinehad A, Rouviere O, Salomon G, Polascik T, Walz J, Wijkstra H, Marberger M. Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel. BJU Int. 2012 Oct; 110(7):942-8. PMID: 22462566.
      Citations: 29     Fields:    Translation:Humans
    214. Matin SF. Editorial comment. Urology. 2012 Apr; 79(4):845; author reply 845. PMID: 22365449.
      Citations:    Fields:    Translation:Humans
    215. Lughezzani G, Burger M, Margulis V, Matin SF, Novara G, Roupret M, Shariat SF, Wood CG, Zigeuner R. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol. 2012 Jul; 62(1):100-14. PMID: 22381168.
      Citations: 124     Fields:    Translation:Humans
    216. Pisters PW, Pettaway CA, Liu P, Matin SF, Ward JF, Leibovici D. Is transureteroureterostomy performed during multi-organ resection for non-urothelial malignancy safe and effective? J Surg Oncol. 2012 Jul 01; 106(1):62-5. PMID: 22259198.
      Citations: 2     Fields:    Translation:Humans
    217. Parker PA, Swartz R, Fellman B, Urbauer D, Li Y, Pisters LL, Rosser CJ, Wood CG, Matin SF. Comprehensive assessment of quality of life and psychosocial adjustment in patients with renal tumors undergoing open, laparoscopic and nephron sparing surgery. J Urol. 2012 Mar; 187(3):822-6. PMID: 22245327; PMCID: PMC3866893.
      Citations: 14     Fields:    Translation:Humans
    218. Shih YC, Ward JF, Pettaway CA, Xu Y, Matin SF, Davis JW, Thompson BP, Elting LS. Comparative effectiveness, cost, and utilization of radical prostatectomy among young men within managed care insurance plans. Value Health. 2012 Mar-Apr; 15(2):367-75. PMID: 22433769.
      Citations: 4     Fields:    Translation:Humans
    219. Jonasch E, McCutcheon IE, Waguespack SG, Wen S, Davis DW, Smith LA, Tannir NM, Gombos DS, Fuller GN, Matin SF. Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease. Ann Oncol. 2011 Dec; 22(12):2661-2666. PMID: 22105611; PMCID: PMC4542805.
      Citations: 36     Fields:    Translation:HumansCTClinical Trials
    220. Andino L, Davis JW, Wei W, Prokhorova IN, Troncoso P, Matin SF. Correlation of histomorphologic findings and partial neurovascular bundle preservation during laparoscopic and robotic radical prostatectomy. J Robot Surg. 2013 Mar; 7(1):1-8. PMID: 27000885.
      Citations:    Fields:    
    221. Tan W, Hildebrandt MA, Pu X, Huang M, Lin J, Matin SF, Tamboli P, Wood CG, Wu X. Role of inflammatory related gene expression in clear cell renal cell carcinoma development and clinical outcomes. J Urol. 2011 Nov; 186(5):2071-7. PMID: 21944129; PMCID: PMC3348612.
      Citations: 17     Fields:    Translation:HumansCells
    222. Chan AA, Ahrar K, Matin SF. Ablative therapies in renal cell carcinoma. Minerva Urol Nefrol. 2011 Sep; 63(3):237-50. PMID: 21993322.
      Citations: 1     Fields:    Translation:Humans
    223. Delacroix SE, Chapin BF, Chen JJ, Nogueras-Gonzalez GM, Tamboli P, Matin SF, Wood CG. Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma? J Urol. 2011 Oct; 186(4):1236-41. PMID: 21849197.
      Citations: 16     Fields:    Translation:Humans
    224. Abel EJ, Karam JA, Carrasco A, Matin SF. Laparoscopic adrenalectomy for metachronous metastases after ipsilateral nephrectomy for renal-cell carcinoma. J Endourol. 2011 Aug; 25(8):1323-7. PMID: 21774667; PMCID: PMC3148128.
      Citations: 7     Fields:    Translation:Humans
    225. Abel EJ, Culp SH, Tannir NM, Tamboli P, Matin SF, Wood CG. Early primary tumor size reduction is an independent predictor of improved overall survival in metastatic renal cell carcinoma patients treated with sunitinib. Eur Urol. 2011 Dec; 60(6):1273-9. PMID: 21784574; PMCID: PMC4378714.
      Citations: 30     Fields:    Translation:Humans
    226. Davis JW, Achim M, Munsell M, Matin S. Effectiveness of postgraduate training for learning extraperitoneal access for robot-assisted radical prostatectomy. J Endourol. 2011 Aug; 25(8):1363-9. PMID: 21745117; PMCID: PMC3180764.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    227. Richey SL, Culp SH, Jonasch E, Matin SF, Wood CG, Tannir NM. Reply to Benefit of cytoreductive nephrectomy in metastatic RCC: do we learn from retrospective studies and small prospective studies? Ann Oncol. 2011 May; 22(5):1243. PMID: 21521725.
      Citations:    Fields:    Translation:Humans
    228. Kaur H, Matin SF, Javadi S, Johnson VE, Choi H, Sandler C, Ahrar K. Chyluria after radiofrequency ablation of renal tumors. J Vasc Interv Radiol. 2011 Jul; 22(7):924-7. PMID: 21507680.
      Citations: 7     Fields:    Translation:Humans
    229. Parikh S, Grossman HB, Katz R, Matin SF, Dinney CP, Kamat AM, Fern?ndez MI. The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for bladder cancer. Urol Oncol. 2012 Nov-Dec; 30(6):821-4. PMID: 21396845; PMCID: PMC3931457.
      Citations: 10     Fields:    Translation:Humans
    230. Rajput MZ, Kamat AM, Clavell-Hernandez J, Siefker-Radtke AO, Grossman HB, Dinney CP, Matin SF. Perioperative outcomes of laparoscopic radical nephroureterectomy and regional lymphadenectomy in patients with upper urinary tract urothelial carcinoma after neoadjuvant chemotherapy. Urology. 2011 Jul; 78(1):61-7. PMID: 21354598; PMCID: PMC3118266.
      Citations: 16     Fields:    Translation:Humans
    231. Karam JA, Rini BI, Varella L, Garcia JA, Dreicer R, Choueiri TK, Jonasch E, Matin SF, Campbell SC, Wood CG, Tannir NM. Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma. J Urol. 2011 Feb; 185(2):439-44. PMID: 21167518; PMCID: PMC4668716.
      Citations: 41     Fields:    Translation:Humans
    232. Karam JA, Ahrar K, Matin SF. Ablation of kidney tumors. Surg Oncol Clin N Am. 2011 Apr; 20(2):341-53, viii. PMID: 21377587.
      Citations: 1     Fields:    Translation:Humans
    233. Richey SL, Culp SH, Jonasch E, Corn PG, Pagliaro LC, Tamboli P, Patel KK, Matin SF, Wood CG, Tannir NM. Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy. Ann Oncol. 2011 May; 22(5):1048-1053. PMID: 21115604; PMCID: PMC4092250.
      Citations: 22     Fields:    Translation:Humans
    234. Clark MA, Shikanov S, Raman JD, Smith B, Kaag M, Russo P, Wheat JC, Wolf JS, Matin SF, Huang WC, Shalhav AL, Eggener SE. Chronic kidney disease before and after partial nephrectomy. J Urol. 2011 Jan; 185(1):43-8. PMID: 21074205.
      Citations: 30     Fields:    Translation:Humans
    235. Abel EJ, Culp SH, Meissner M, Matin SF, Tamboli P, Wood CG. Identifying the risk of disease progression after surgery for localized renal cell carcinoma. BJU Int. 2010 Nov; 106(9):1277-83. PMID: 20394619.
      Citations: 10     Fields:    Translation:Humans
    236. Dhillon J, Tannir NM, Matin SF, Tamboli P, Czerniak BA, Guo CC. Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes. Hum Pathol. 2011 Jan; 42(1):146-50. PMID: 20971497; PMCID: PMC4163005.
      Citations: 20     Fields:    Translation:Humans
    237. Abel EJ, Culp SH, Tannir NM, Matin SF, Tamboli P, Jonasch E, Wood CG. Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma. Eur Urol. 2011 Jan; 59(1):10-5. PMID: 20952123; PMCID: PMC4378833.
      Citations: 35     Fields:    Translation:Humans
    238. Sundi D, Svatek RS, Margulis V, Wood CG, Matin SF, Dinney CP, Kamat AM. Upper tract urothelial carcinoma: impact of time to surgery. Urol Oncol. 2012 May-Jun; 30(3):266-72. PMID: 20869888; PMCID: PMC3034106.
      Citations: 17     Fields:    Translation:Humans
    239. Karam JA, Ahrar K, Wood CG, Jonasch E, Vikram R, Romero C, Tannir N, Matin SF. Radio frequency ablation of renal tumors in patients with metastatic renal cell carcinoma. J Urol. 2010 Nov; 184(5):1882-7. PMID: 20846689; PMCID: PMC4777338.
      Citations: 2     Fields:    Translation:Humans
    240. Abel EJ, Culp SH, Matin SF, Tamboli P, Wallace MJ, Jonasch E, Tannir NM, Wood CG. Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment. J Urol. 2010 Nov; 184(5):1877-81. PMID: 20850148; PMCID: PMC4809737.
      Citations: 21     Fields:    Translation:Humans
    241. Matin SF, Kamat AM, Grossman HB. High-frequency endoluminal ultrasonography as an aid to the staging of upper tract urothelial carcinoma: imaging findings and pathologic correlation. J Ultrasound Med. 2010 Sep; 29(9):1277-84. PMID: 20733182.
      Citations: 9     Fields:    Translation:Humans
    242. Culp SH, Tannir NM, Abel EJ, Margulis V, Tamboli P, Matin SF, Wood CG. Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy? Cancer. 2010 Jul 15; 116(14):3378-88. PMID: 20564061.
      Citations: 66     Fields:    Translation:Humans
    243. Matin SF, Margulis V, Kamat A, Wood CG, Grossman HB, Brown GA, Dinney CP, Millikan R, Siefker-Radtke AO. Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer. 2010 Jul 01; 116(13):3127-34. PMID: 20564621.
      Citations: 59     Fields:    Translation:Humans
    244. Hoang AN, Vaporcyian AA, Matin SF. Laparoscopy-assisted radical nephrectomy with inferior vena caval thrombectomy for level II to III tumor thrombus: a single-institution experience and review of the literature. J Endourol. 2010 Jun; 24(6):1005-12. PMID: 20491594.
      Citations: 9     Fields:    Translation:Humans
    245. Childs MA, Wood CG, Spiess PE, Debiane LG, Hernandez M, Matin SF, Millikan RE, Siefker-Radtkie A, Scott SM, Pisters LL. Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy. Can J Urol. 2010 Jun; 17(3):5184-9. PMID: 20566011.
      Citations: 4     Fields:    Translation:Humans
    246. Svatek RS, Fisher MB, Williams MB, Matin SF, Kamat AM, Grossman HB, Urbauer DL, Dinney CP, Nogueras-Gonz?lez GM. Age and body mass index are independent risk factors for the development of postoperative paralytic ileus after radical cystectomy. Urology. 2010 Dec; 76(6):1419-24. PMID: 20472264.
      Citations: 33     Fields:    Translation:Humans
    247. Shikanov S, Lifshitz D, Chan AA, Okhunov Z, Ordonez MA, Wheat JC, Matin SF, Landman J, Wolf JS, Eggener SE, Shalhav AL. Impact of ischemia on renal function after laparoscopic partial nephrectomy: a multicenter study. J Urol. 2010 May; 183(5):1714-8. PMID: 20299052.
      Citations: 16     Fields:    Translation:Humans
    248. Matin SF. Determining failure after renal ablative therapy for renal cell carcinoma: false-negative and false-positive imaging findings. Urology. 2010 Jun; 75(6):1254-7. PMID: 20299082.
      Citations: 3     Fields:    Translation:Humans
    249. Javadi S, Ahrar JU, Ninan E, Gupta S, Matin SF, Ahrar K. Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors. J Vasc Interv Radiol. 2010 May; 21(5):690-5. PMID: 20227295.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    250. Svatek RS, Fisher MB, Matin SF, Kamat AM, Grossman HB, Urbauer DL, Kennedy KA, Dinney CP, Nogueras-Gonz?lez GM. Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteria. J Urol. 2010 Mar; 183(3):929-34. PMID: 20083264.
      Citations: 22     Fields:    Translation:Humans
    251. Matin SF, Sharma P, Gill IS, Tannenbaum C, Hobart MG, Novick AC, Finke JH. Immunological response to renal cryoablation in an in vivo orthotopic renal cell carcinoma murine model. J Urol. 2010 Jan; 183(1):333-8. PMID: 19914660.
      Citations: 12     Fields:    Translation:Animals
    252. Chan AA, Wood CG, Caicedo J, Munsell MF, Matin SF. Predictors of unilateral renal function after open and laparoscopic partial nephrectomy. Urology. 2010 Feb; 75(2):295-302. PMID: 19963245.
      Citations: 10     Fields:    Translation:Humans
    253. Chen M, Ye Y, Yang H, Tamboli P, Matin S, Tannir NM, Wood CG, Gu J, Wu X. Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays. Int J Cancer. 2009 Nov 15; 125(10):2342-8. PMID: 19521957; PMCID: PMC2768265.
      Citations: 38     Fields:    Translation:HumansCells
    254. Matin SF. Emergence of robot-assisted partial nephrectomy. Nat Rev Urol. 2009 Nov; 6(11):579-80. PMID: 19890335.
      Citations:    Fields:    Translation:Humans
    255. Davis JW, Kamat A, Munsell M, Pettaway C, Pisters L, Matin S. Initial experience of teaching robot-assisted radical prostatectomy to surgeons-in-training: can training be evaluated and standardized? BJU Int. 2010 Apr; 105(8):1148-54. PMID: 19874300.
      Citations: 12     Fields:    Translation:Humans
    256. Chiong E, Hegarty PK, Davis JW, Kamat AM, Pisters LL, Matin SF. Port-site hernias occurring after the use of bladeless radially expanding trocars. Urology. 2010 Mar; 75(3):574-80. PMID: 19854489.
      Citations: 22     Fields:    Translation:Humans
    257. Fisher MB, Svatek RS, Hegarty PK, McGinniss JE, Hightower C, Grossman HB, Kamat AM, Dinney CP, Matin SF. Cardiac history and risk of post-cystectomy cardiac complications. Urology. 2009 Nov; 74(5):1085-9. PMID: 19758689; PMCID: PMC2784244.
      Citations: 3     Fields:    Translation:Humans
    258. Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG, Practice Guidelines Committee of the American Urological Association. Guideline for management of the clinical T1 renal mass. J Urol. 2009 Oct; 182(4):1271-9. PMID: 19683266.
      Citations: 481     Fields:    Translation:Humans
    259. Raman JD, Raj GV, Lucas SM, Williams SK, Lauer EM, Ahrar K, Matin SF, Leveillee RJ, Cadeddu JA. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int. 2010 Feb; 105(4):496-500. PMID: 19681900.
      Citations: 20     Fields:    Translation:Humans
    260. Jonasch E, Wood CG, Matin SF, Tu SM, Pagliaro LC, Corn PG, Aparicio A, Tamboli P, Millikan RE, Wang X, Araujo JC, Arap W, Tannir N. Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma. J Clin Oncol. 2009 Sep 01; 27(25):4076-81. PMID: 19636008; PMCID: PMC4371138.
      Citations: 56     Fields:    Translation:HumansCTClinical Trials
    261. Zorn KC, Gautam G, Shalhav AL, Clayman RV, Ahlering TE, Albala DM, Lee DI, Sundaram CP, Matin SF, Castle EP, Winfield HN, Gettman MT, Lee BR, Thomas R, Patel VR, Leveillee RJ, Wong C, Badlani GH, Rha KH, Eggener SE, Wiklund P, Mottrie A, Atug F, Kural AR, Joseph JV, Members of the Society of Urologic Robotic Surgeons. Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: recommendations of the society of urologic robotic surgeons. J Urol. 2009 Sep; 182(3):1126-32. PMID: 19625032.
      Citations: 47     Fields:    Translation:Humans
    262. Vikram R, Ng CS, Tamboli P, Tannir NM, Jonasch E, Matin SF, Wood CG, Sandler CM. Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Radiographics. 2009 May-Jun; 29(3):741-54; discussion 755-7. PMID: 19448113.
      Citations: 37     Fields:    Translation:Humans
    263. Matin SF, Feeley T, Kennamer D, Corriere JN, Miles M, Kays C, Green H, Craig CE, Dinney CP. Office cystoscopy and transrectal ultrasound-guided prostate biopsies pose minimal risk: prospective evaluation of 921 procedures. Urology. 2009 Jun; 73(6):1175-8. PMID: 19362332.
      Citations: 3     Fields:    Translation:Humans
    264. Shah SK, Matin SF, Singer EA, Eichel L, Kim HL. Outcomes of laparoscopic partial nephrectomy after fellowship training. JSLS. 2009 Apr-Jun; 13(2):154-9. PMID: 19660208; PMCID: PMC3015948.
      Citations: 3     Fields:    Translation:Humans
    265. Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG, Upper Tract Urothelial Carcinoma CollaborationThe Upper Tract Urothelial Carcinoma Collaboration. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009 Mar 15; 115(6):1224-33. PMID: 19156917.
      Citations: 290     Fields:    Translation:Humans
    266. Clague J, Lin J, Cassidy A, Matin S, Tannir NM, Tamboli P, Wood CG, Wu X. Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis. Cancer Epidemiol Biomarkers Prev. 2009 Mar; 18(3):801-7. PMID: 19240244; PMCID: PMC2747496.
      Citations: 38     Fields:    Translation:Humans
    267. Jimenez C, Cabanillas ME, Santarpia L, Jonasch E, Kyle KL, Lano EA, Matin SF, Nunez RF, Perrier ND, Phan A, Rich TA, Shah B, Williams MD, Waguespack SG. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors. J Clin Endocrinol Metab. 2009 Feb; 94(2):386-91. PMID: 19017755.
      Citations: 42     Fields:    Translation:Humans
    268. Margulis V, Matin SF, Tannir N, Tamboli P, Shen Y, Lozano M, Swanson DA, Jonasch E, Wood CG. Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinoma. Urology. 2009 Feb; 73(2):337-41. PMID: 18950837; PMCID: PMC4723280.
      Citations: 8     Fields:    Translation:Humans
    269. Margulis V, Matin SF, Wood CG. Cytoreductive nephrectomy in metastatic renal cell carcinoma. Curr Opin Urol. 2008 Sep; 18(5):474-80. PMID: 18670270.
      Citations: 6     Fields:    Translation:Humans
    270. Lin J, Pu X, Wang W, Matin S, Tannir NM, Wood CG, Wu X. Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma. Carcinogenesis. 2008 Nov; 29(11):2112-9. PMID: 18711149; PMCID: PMC2722861.
      Citations: 11     Fields:    Translation:HumansCells
    271. Rich TA, Jonasch E, Matin S, Waguespack SG, Gombos DS, Santarpia L, Stolle C, Jimenez C. A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma. Cancer Invest. 2008 Jul; 26(6):642-6. PMID: 18584357.
      Citations: 1     Fields:    Translation:HumansCells
    272. Matin SF, Tinkey PT, Borne AT, Stephens LC, Sherz A, Swanson DA. A pilot trial of vascular targeted photodynamic therapy for renal tissue. J Urol. 2008 Jul; 180(1):338-42. PMID: 18499165; PMCID: PMC2696069.
      Citations: 1     Fields:    Translation:Animals
    273. Matin SF, Ahrar K, Wood CG, Daniels M, Jonasch E. Patterns of intervention for renal lesions in von Hippel-Lindau disease. BJU Int. 2008 Sep; 102(8):940-5. PMID: 18485044.
      Citations: 10     Fields:    Translation:Humans
    274. Margulis V, Matin SF, Tannir N, Tamboli P, Swanson DA, Jonasch E, Wood CG. Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma. J Urol. 2008 Jul; 180(1):94-8. PMID: 18485389.
      Citations: 41     Fields:    Translation:Humans
    275. Margulis V, Wood CG, Jonasch E, Matin SF. Current status of debulking nephrectomy in the era of tyrosine kinase inhibitors. Curr Oncol Rep. 2008 May; 10(3):253-8. PMID: 18765156.
      Citations: 2     Fields:    Translation:Humans
    276. Margulis V, Tamboli P, Matin SF, Swanson DA, Wood CG. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer. 2008 Apr 01; 112(7):1480-8. PMID: 18240184.
      Citations: 25     Fields:    Translation:Humans
    277. Ponsky L, Cherullo E, Moinzadeh A, Desai M, Kaouk J, Haber GP, Chen D, Ng C, Fuchs G, Singh D, Finelli A, Frank I, Matin S. The Hem-o-lok clip is safe for laparoscopic nephrectomy: a multi-institutional review. Urology. 2008 Apr; 71(4):593-6. PMID: 18295866.
      Citations: 15     Fields:    Translation:Humans
    278. Matin SF, Ahrar K. Nephron-sparing probe ablative therapy: long-term outcomes. Curr Opin Urol. 2008 Mar; 18(2):150-6. PMID: 18303535.
      Citations: 4     Fields:    Translation:Humans
    279. Busby JE, Brown GA, Matin SF. Comparing lymphadenectomy during radical nephroureterectomy: open versus laparoscopic. Urology. 2008 Mar; 71(3):413-6. PMID: 18342175.
      Citations: 6     Fields:    Translation:Humans
    280. Chung BI, Matin SF, Ost MC, Winfield HN. Fellowship in endourology, the job search, and setting up a successful practice: an insider's view. J Endourol. 2008 Mar; 22(3):551-7. PMID: 18307381.
      Citations: 1     Fields:    
    281. Sabichi AL, Lerner SP, Atkinson EN, Grossman HB, Caraway NP, Dinney CP, Penson DF, Matin S, Kamat A, Pisters LL, Lin DW, Katz RL, Brenner DE, Hemstreet GP, Wargo M, Bleyer A, Sanders WH, Clifford JL, Parnes HL, Lippman SM. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res. 2008 Jan 01; 14(1):224-9. PMID: 18172274.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    282. Booth J, Matin SF, Ahrar K, Tamboli P, Wood CG. Contemporary strategies for treating nonhereditary synchronous bilateral renal tumors and the impact of minimally invasive, nephron-sparing techniques. Urol Oncol. 2008 Jan-Feb; 26(1):37-42. PMID: 18190828.
      Citations: 4     Fields:    Translation:Humans
    283. Kundra V, Silverman PM, Matin SF, Choi H. Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer. AJR Am J Roentgenol. 2007 Oct; 189(4):830-44. PMID: 17885053.
      Citations: 12     Fields:    Translation:HumansPHPublic Health
    284. Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. J Urol. 2007 Nov; 178(5):1878-82. PMID: 17868733.
      Citations: 14     Fields:    Translation:Humans
    285. Kassouf W, Sanchez-Ortiz R, Tamboli P, Tannir N, Jonasch E, Merchant MM, Matin S, Swanson DA, Wood CG. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology. J Urol. 2007 Nov; 178(5):1896-900. PMID: 17868729.
      Citations: 23     Fields:    Translation:Humans
    286. Javadi S, Matin SF, Tamboli P, Ahrar K. Unexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy. J Vasc Interv Radiol. 2007 Sep; 18(9):1186-91. PMID: 17804784.
      Citations: 6     Fields:    Translation:Humans
    287. Shao L, Wood CG, Zhang D, Tannir NM, Matin S, Dinney CP, Wu X. Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. J Urol. 2007 Oct; 178(4 Pt 1):1492-6. PMID: 17707063.
      Citations: 44     Fields:    Translation:HumansCells
    288. Brown GA, Matin SF, Busby JE, Dinney CP, Grossman HB, Pettaway CA, Munsell MF, Kamat AM. Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy. Urology. 2007 Aug; 70(2):252-6. PMID: 17826484; PMCID: PMC2034451.
      Citations: 27     Fields:    Translation:Humans
    289. Black PC, Basen-Engquist K, Wang X, Swartz RJ, Eddings T, Matin SF, Swanson D, Wood CG, Pisters LL, Babaian RJ, Troncoso P, Pettaway CA. A randomized prospective trial evaluating testosterone, haemoglobin kinetics and quality of life, during and after 12 months of androgen deprivation after prostatectomy: results from the Postoperative Adjuvant Androgen Deprivation trial. BJU Int. 2007 Jul; 100(1):63-9. PMID: 17552954.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    290. Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system. Cancer. 2007 Jun 15; 109(12):2439-44. PMID: 17487856.
      Citations: 11     Fields:    Translation:Humans
    291. Jacobsohn KM, Ahrar K, Wood CG, Matin SF. Is radiofrequency ablation safe for solitary kidneys? Urology. 2007 May; 69(5):819-23; discussion 823. PMID: 17482911.
      Citations: 9     Fields:    Translation:Humans
    292. Busby JE, Matin SF. Laparoscopic radical nephroureterectomy for transitional cell carcinoma: where are we in 2007? Curr Opin Urol. 2007 Mar; 17(2):83-7. PMID: 17285015.
      Citations: 3     Fields:    Translation:Humans
    293. Kader AK, Tamboli P, Luongo T, Matin SF, Bell K, Jonasch E, Swanson DA, Wood CG. Cytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experience. J Urol. 2007 Mar; 177(3):855-60; discussion 860-1. PMID: 17296358.
      Citations: 12     Fields:    Translation:Humans
    294. Brown GA, Matin SF. Laparoscopic partial nephrectomy: experience in 60 cases. J Endourol. 2007 Jan; 21(1):71-4. PMID: 17263612.
      Citations: 4     Fields:    Translation:Humans
    295. Ahrar K, Wallace MJ, Matin SF. Percutaneous radiofrequency ablation: minimally invasive therapy for renal tumors. Expert Rev Anticancer Ther. 2006 Dec; 6(12):1735-44. PMID: 17181487.
      Citations: 3     Fields:    Translation:Humans
    296. Brown GA, Busby JE, Wood CG, Pisters LL, Dinney CP, Swanson DA, Grossman HB, Pettaway CA, Munsell MF, Kamat AM, Matin SF. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm? BJU Int. 2006 Dec; 98(6):1176-80. PMID: 17125474.
      Citations: 30     Fields:    Translation:Humans
    297. Matin SF, Dhanani N, Acosta M, Wood CG. Conventional and hand-assisted laparoscopic radical nephrectomy: Comparative analysis of 271 cases. J Endourol. 2006 Nov; 20(11):891-4. PMID: 17144857.
      Citations: 3     Fields:    Translation:Humans
    298. Matin SF, Ahrar K, Cadeddu JA, Gervais DA, McGovern FJ, Zagoria RJ, Zagoria RA, Uzzo RG, Haaga J, Resnick MI, Kaouk J, Gill IS. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol. 2006 Nov; 176(5):1973-7. PMID: 17070224.
      Citations: 40     Fields:    Translation:Humans
    299. Matin SF, Madsen LT, Wood CG. Laparoscopic cytoreductive nephrectomy: the M. D. Anderson Cancer Center experience. Urology. 2006 Sep; 68(3):528-32. PMID: 16979706.
      Citations: 13     Fields:    Translation:Humans
    300. Matin SF, Jonasch E. Targeting von Hippel-Lindau syndrome: the future is now. Future Oncol. 2006 Jun; 2(3):321-3. PMID: 16787109.
      Citations:    Fields:    Translation:Humans
    301. Matin SF. Recognition and preservation of accessory pudendal arteries during laparoscopic radical prostatectomy. Urology. 2006 May; 67(5):1012-5. PMID: 16635507.
      Citations: 5     Fields:    Translation:Humans
    302. Goel MC, Matin SF, Derweesh I, Levin H, Streem S, Novick AC. Partial nephrectomy for renal urothelial tumors: clinical update. Urology. 2006 Mar; 67(3):490-5. PMID: 16527564.
      Citations: 3     Fields:    Translation:Humans
    303. Busby JE, Brown GA, Tamboli P, Kamat AM, Dinney CP, Grossman HB, Matin SF. Upper urinary tract tumors with nontransitional histology: a single-center experience. Urology. 2006 Mar; 67(3):518-23. PMID: 16527570.
      Citations: 21     Fields:    Translation:Humans
    304. Lee LS, Yip SK, Cheng WS. Re: Recurrence and survival following laparoscopic radical nephroureterectomy with various forms of bladder cuff control. J Urol. 2006 Jan; 175(1):391-2; author reply 392-3. PMID: 16406949.
      Citations:    Fields:    Translation:Humans
    305. Berglund RK, Matin SF, Desai M, Kaouk J, Gill IS. Laparoscopic radical cystoprostatectomy with bilateral nephroureterectomy: initial report. BJU Int. 2006 Jan; 97(1):37-41. PMID: 16336325.
      Citations: 8     Fields:    Translation:Humans
    306. Naude AM, Heyns CF, Matin SF. Laparoscopic urology training in South Africa. J Endourol. 2005 Dec; 19(10):1180-4. PMID: 16359210.
      Citations: 3     Fields:    Translation:Humans
    307. Ahrar K, Matin S, Wallace MJ, Gupta S, Hicks ME. Percutaneous transthoracic radiofrequency ablation of renal tumors using an iatrogenic pneumothorax. AJR Am J Roentgenol. 2005 Jul; 185(1):86-8. PMID: 15972404.
      Citations: 5     Fields:    Translation:Humans
    308. Cohen DD, Matin SF, Steinberg JR, Zagone R, Wood CG. Evaluation of the intact specimen after laparoscopic radical nephrectomy for clinically localized renal cell carcinoma identifies a subset of patients at increased risk for recurrence. J Urol. 2005 May; 173(5):1487-90; discussion 1490-1. PMID: 15821465.
      Citations: 3     Fields:    Translation:Humans
    309. Ahrar K, Matin S, Wood CG, Wallace MJ, Gupta S, Madoff DC, Rao S, Tannir NM, Jonasch E, Pisters LL, Rozner MA, Kennamer DL, Hicks ME. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J Vasc Interv Radiol. 2005 May; 16(5):679-88. PMID: 15872323.
      Citations: 20     Fields:    Translation:Humans
    310. Matin SF. Radical laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: current status. BJU Int. 2005 Mar; 95 Suppl 2:68-74. PMID: 15720338.
      Citations: 2     Fields:    Translation:Humans
    311. Stage AC, Pollock RE, Matin SF. Bilateral metastatic renal synovial sarcoma. Urology. 2005 Feb; 65(2):389. PMID: 15708068.
      Citations: 4     Fields:    Translation:Humans
    312. Matin SF, Gill IS. Recurrence and survival following laparoscopic radical nephroureterectomy with various forms of bladder cuff control. J Urol. 2005 Feb; 173(2):395-400. PMID: 15643179.
      Citations: 27     Fields:    Translation:Humans
    313. Highshaw RA, Vakar-Lopez F, Jonasch E, Yasko AW, Matin SF. Port-site metastasis: the influence of biology. Eur Urol. 2005 Mar; 47(3):357-60. PMID: 15716201.
      Citations: 4     Fields:    Translation:Humans
    314. Desai MM, Strzempkowski B, Matin SF, Steinberg AP, Ng C, Meraney AM, Kaouk JH, Gill IS. Prospective randomized comparison of transperitoneal versus retroperitoneal laparoscopic radical nephrectomy. J Urol. 2005 Jan; 173(1):38-41. PMID: 15592021.
      Citations: 37     Fields:    Translation:HumansCTClinical Trials
    315. Schoor RA, Ross LS, Niederberger CS. Re: initial evaluation of robotic technology for microsurgical vasovasostomy. J Urol. 2004 Aug; 172(2):780; author reply 780-1. PMID: 15247793.
      Citations:    Fields:    Translation:Humans
    316. Steinberg JR, Matin SF. Laparoscopic radical nephroureterectomy: dilemma of the distal ureter. Curr Opin Urol. 2004 Mar; 14(2):61-5. PMID: 15075832.
      Citations: 12     Fields:    Translation:Humans
    317. Kuang W, Shin PR, Matin S, Thomas AJ. Initial evaluation of robotic technology for microsurgical vasovasostomy. J Urol. 2004 Jan; 171(1):300-3. PMID: 14665899.
      Citations: 20     Fields:    Translation:Humans
    318. Matin SF. Laparoscopic approaches to urologic malignancies. Curr Treat Options Oncol. 2003 Oct; 4(5):373-83. PMID: 12941197.
      Citations: 2     Fields:    Translation:Humans
    319. Matin SF, Abreu S, Ramani A, Steinberg AP, Desai M, Strzempkowski B, Yang Y, Shen Y, Gill IS. Evaluation of age and comorbidity as risk factors after laparoscopic urological surgery. J Urol. 2003 Oct; 170(4 Pt 1):1115-20. PMID: 14501704.
      Citations: 13     Fields:    Translation:Humans
    320. Matin SF, Yost A, Streem SB. Ureteroscopic laser endopyelotomy: a single-center experience. J Endourol. 2003 Aug; 17(6):401-4. PMID: 12965067.
      Citations: 10     Fields:    Translation:Humans
    321. Gill IS, Matin SF, Desai MM, Kaouk JH, Steinberg A, Mascha E, Thornton J, Sherief MH, Strzempkowski B, Novick AC. Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J Urol. 2003 Jul; 170(1):64-8. PMID: 12796646.
      Citations: 97     Fields:    Translation:Humans
    322. Matin SF. Prospective randomized trial of skin adhesive versus sutures for closure of 217 laparoscopic port-site incisions. J Am Coll Surg. 2003 Jun; 196(6):845-53. PMID: 12788419.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    323. Desai MM, Gill IS, Goel M, Abreu SC, Ramani AP, Bedaiwy MA, Kaouk JH, Matin SF, Steinberg AP, Brainard J, Robertson D, Sung GT. Ureteral tissue balloon expansion for laparoscopic bladder augmentation: survival study. J Endourol. 2003 Jun; 17(5):283-93. PMID: 12885353.
      Citations: 3     Fields:    Translation:Animals
    324. Matin SF, Gill IS. Modified Pfannenstiel incision for intact specimen extraction after retroperitoneoscopic renal surgery. Urology. 2003 Apr; 61(4):830-2. PMID: 12670577.
      Citations: 6     Fields:    Translation:Humans
    325. Desai MM, Gill IS, Ramani AP, Matin SF, Kaouk JH, Campero JM. Laparoscopic radical nephrectomy for cancer with level I renal vein involvement. J Urol. 2003 Feb; 169(2):487-91. PMID: 12544294.
      Citations: 10     Fields:    Translation:Humans
    326. Desai MM, Gill IS, Kaouk JH, Matin SF, Novick AC. Laparoscopic partial nephrectomy with suture repair of the pelvicaliceal system. Urology. 2003 Jan; 61(1):99-104. PMID: 12559277.
      Citations: 7     Fields:    Translation:Humans
    327. Bandyopadhyay SK, Rackley RR, Matin SF, Sadhukhan PC. Interferon-alpha response and signal transduction pathway in transitional carcinoma cell lines. Adv Exp Med Biol. 2003; 539(Pt A):15-32. PMID: 15088893.
      Citations: 1     Fields:    Translation:HumansCells
    328. Desai MM, Gill IS, Kaouk JH, Matin SF, Sung GT, Bravo EL. Robotic-assisted laparoscopic adrenalectomy. Urology. 2002 Dec; 60(6):1104-7. PMID: 12475680.
      Citations: 24     Fields:    Translation:Humans
    329. Matin SF, Hsu TH, Klein EA, Streem SB. Acute renal failure due to subcapsular renal hematoma in a solitary kidney: improvement after decompression. J Urol. 2002 Dec; 168(6):2526-7. PMID: 12441956.
      Citations: 3     Fields:    Translation:Humans
    330. Kaouk JH, Matin S, Bravo EL, Gill IS. Laparoscopic bilateral partial adrenalectomy for pheochromocytoma. Urology. 2002 Dec; 60(6):1100-3. PMID: 12475679.
      Citations: 6     Fields:    Translation:Humans
    331. Kuang W, Ng CS, Matin S, Kaouk JH, El-Jack M, Gill IS. Rhabdomyolysis after laparoscopic donor nephrectomy. Urology. 2002 Nov; 60(5):911. PMID: 12429334.
      Citations: 5     Fields:    Translation:Humans
    332. Matin SF, Gill IS, Worley S, Novick AC. Outcome of laparoscopic radical and open partial nephrectomy for the sporadic 4 cm. or less renal tumor with a normal contralateral kidney. J Urol. 2002 Oct; 168(4 Pt 1):1356-9; discussion 1359-60. PMID: 12352392.
      Citations: 21     Fields:    Translation:Humans
    333. Matin SF, Gill IS. Laparoscopic radical cystectomy with urinary diversion: completely intracorporeal technique. J Endourol. 2002 Aug; 16(6):335-41; discussion 341. PMID: 12227904.
      Citations: 9     Fields:    Translation:Humans
    334. Matin SF, Gill IS. Laparoscopic radical nephrectomy: retroperitoneal versus transperitoneal approach. Curr Urol Rep. 2002 Apr; 3(2):164-71. PMID: 12084210.
      Citations: 4     Fields:    Translation:Humans
    335. Goldfarb DA, Matin SF, Braun WE, Schreiber MJ, Mastroianni B, Papajcik D, Rolin HA, Flechner S, Goormastic M, Novick AC. Renal outcome 25 years after donor nephrectomy. J Urol. 2001 Dec; 166(6):2043-7. PMID: 11696703.
      Citations: 48     Fields:    Translation:Humans
    336. Matin SF, Yost A, Streem SB. Extracorporeal shock-wave lithotripsy: a comparative study of electrohydraulic and electromagnetic units. J Urol. 2001 Dec; 166(6):2053-6. PMID: 11696705.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    337. Hsu TH, Matin SF. Benign prostatic hyperplasia mimicking bladder tumor. Urology. 2001 Jun; 57(6):1166. PMID: 11377336.
      Citations: 1     Fields:    Translation:Humans
    338. Matin SF, Rackley RR, Sadhukhan PC, Kim MS, Novick AC, Bandyopadhyay SK. Impaired alpha-interferon signaling in transitional cell carcinoma: lack of p48 expression in 5637 cells. Cancer Res. 2001 Mar 01; 61(5):2261-6. PMID: 11280796.
      Citations: 11     Fields:    Translation:HumansCells
    339. Matin SF, Novick AC. Renal dysfunction associated with staged bilateral partial nephrectomy: the importance of operative positioning. J Urol. 2001 Mar; 165(3):880-1. PMID: 11176491.
      Citations: 4     Fields:    Translation:Humans
    340. Matin SF, Gill IS. Laparoscopic ultrasonography. J Endourol. 2001 Feb; 15(1):87-92. PMID: 11248925.
      Citations: 6     Fields:    Translation:Humans
    341. Matin SF, Streem SB. Metabolic risk factors in patients with ureteropelvic junction obstruction and renal calculi. J Urol. 2000 Jun; 163(6):1676-8. PMID: 10799158.
      Citations: 6     Fields:    Translation:Humans
    342. Matin SF, Gill IS. Laparoscopic marsupialization of the difficult lymphocele using internalized peritoneal dialysis catheter. J Urol. 2000 May; 163(5):1498-500. PMID: 10751865.
      Citations:    Fields:    Translation:Humans
    343. Tipton KD, Gurkin BE, Matin S, Wolfe RR. Nonessential amino acids are not necessary to stimulate net muscle protein synthesis in healthy volunteers. J Nutr Biochem. 1999 Feb; 10(2):89-95. PMID: 15539275.
      Citations: 60     Fields:    
    344. Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN). European Urology.
    345. Preoperative patient counseling for diagnostic renal biopsy and complications with renal radiofrequency ablation. Journal of Endourology. 26:425-426.
    346. Commentary. Journal of Endourology. 24:1717-1718.
    347. Cryoablation for cT1b Renal Tumors? Yet To Be Determined. European Urology. 71:118-119.
    348. Thermal/ablative technology. Journal of Endourology. 23:1803-1805.
    349. Management and outcomes of patients with renal medullary carcinoma. BJU International.
    350. Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy. Journal of Urology.
    351. Resistance to antiangiogenic therapy is associated with an immunosuppressive tumor microenvironment in metastatic Renal cell carcinoma. Cancer immunology research. 3:1017-1029.
    352. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016. World Journal of Urology. 1-9.
    353. Laparoscopic ultrasonography. 7-15.
    354. Inferior vena cava atresia associated with von hippel-lindau masquerading as metastatic testicular cancer. Current Urology. 2:214-216.
    355. In vivo microwave-induced porcine kidney thermoablation. Journal of Endourology. 25:908-909.
    356. Editorial Comment. Journal of Urology. 181:2475.
    357. Prostate cancer. 377-402.
    358. Energy ablative techniques in renal cell carcinoma. 141-162.
    359. Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney. BJU International.
    360. Genomic DNA hypomethylation and risk of renal cell carcinoma. Clinical Cancer Research. 22:2074-2082.
    361. Multiple Renal Artery Pseudoaneurysms in Patients Undergoing Renal Artery Embolization Following Partial Nephrectomy. CardioVascular and Interventional Radiology. 1-8.
    362. Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation. Urologic Oncology: Seminars and Original Investigations. 33:166.e21-166.e29.
    363. Kidney cancer. 133-142.
    364. Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases. BJU International.
    365. Contemporary Evaluation and Management of Upper Tract Urothelial Cancer. Urology. 94:17-23.
    366. Renal tumors. 287-309.
    367. Renal angiomyolipoma. 565-586.
    368. Prognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy. Urologic Oncology: Seminars and Original Investigations.
    369. Correlation of histomorphologic findings and partial neurovascular bundle preservation during laparoscopic and robotic radical prostatectomy. Journal of Robotic Surgery. 7:1-8.
    370. Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma. Oncogene.
    371. Surgical and medical treatment. 377-399.
    372. Reply by the Authors. Urology. 72:949-950.
    373. MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity. British Journal of Cancer. 116:77-84.
    374. Metastases to the kidney. BJU International.
    375. Renal ischemia and approach to the renal hilum. 287-294.
    376. The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation. Journal of Urology.
    377. Posttraumatic stress and depressive symptoms in renal cell carcinoma. Psycho-Oncology.
    378. Tribute to Dr. David Swanson. Urology.
    379. Kidney cancer. Nature Reviews Urology.
    380. Examination of moderators of expressive writing in patients with renal cell carcinoma. Psycho-Oncology.
    381. Editorial Comment. Urology. 69:645-646.
    382. Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation. Urologic Oncology: Seminars and Original Investigations. 33:427.e17-427.e23.
    383. Editorial Comment. Journal of Urology. 178:50.
    384. Upper tract urothelial carcinoma. Minerva Urologica e Nefrologica. 68:350-358.
    385. Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles - Commentary. Journal of Endourology. 25:909-910.
    386. Upper Urinary Tract Carcinoma In Situ. Journal of Urology. 197:287-295.
    387. Perioperative outcomes of laparoscopic radical nephroureterectomy and regional lymphadenectomy in patients with upper urinary tract urothelial carcinoma after neoadjuvant chemotherapy. Journal of Urology. 186:453.
    388. Thermal/ablative technology. Journal of Endourology. 24:1716-1717.
    389. Special considerations in laparoscopy. 333-342.
    390. Predicting and Determining the Success of Percutaneous Ablation. Journal of Urology.
    391. Surveillance strategies following curative therapy for localized renal cell carcinoma. 265-273.
    392. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805). The Lancet.
    393. Feasibility and outcomes of repeat partial nephrectomy. Journal of Endourology. 22:2425-2426.
    394. Editorial Comment. Urology. 100:150.
    395. Reply. Urology. 69:823.
    396. Authors' response. Radiographics. 29:757.
    397. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016. World Journal of Urology. 1-11.
    398. Commentary. Journal of Endourology. 24:897-898.
    399. Commentary. Journal of Endourology. 27:1328-1329.
    400. Editorial Comment. Journal of Urology. 176:2395.
    401. A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy. European Urology.
    402. Impact of warm versus cold ischemia on renal function following partial nephrectomy. World Journal of Urology. 33:351-357.
    403. Conservative management of low-risk utuc. 119-130.
    404. Neoadjuvant Systemic Therapy before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity. Clinical Genitourinary Cancer. 14:130-138.
    MATIN's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (600)
    Explore
    _
    Co-Authors (143)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _